>FMHLFHII_00001 hypothetical protein
MSSLTLFIFFLQLFIFTSSVSGISIKRCTEEENNTWEIEVGLCIQTENFRAIKTGCYKIQ
GPGGLLTEGNGFKIFAHDDCSKEETQNNFILDSVNEAVYALGKYVYMEISTSNITTLYSL
PQCAKRISLSISCDQVTTEMKSYVESVSFKDYDLEFVITTDISCVKHVSSSVIVRNECEK
KYISTGKKIFGFNNKIDCSAVKFSEHVNYLKTCSVGKFDRKKYYEHQHNYIKKIFHHNEL
>FMHLFHII_00002 Viral interleukin-10 
MKTNTKIILFCYVILSLYVFSCAIASAKKCDDVSFDYILKDLRSEFSKIKSFVQDNDQEN
MMLLSQSMLDKLTSRIGCKSLSDMIKFYLNDVLPNAEKIEHMKNKITSIGEKLKSLKEKL
ISCDFLHCENHDEIKTVKTIFNKLKDKGIYKAMGEFDIFINYLEKYIVKK
>FMHLFHII_00003 hypothetical protein
MKVINFIILICCFKSAFLSEYCKYRGGILTPVNVNFKDPAFLKCPLDNYKKSIFFKKNIT
SYDITWFQTNSLSFVRNYNDYKNFKKIEVNNENASRVQLIGNNLWLYPVINIDDGIYICR
FRSHNICEEMSIKLTFLDKEETITYRFNEGLNSTVHCMDIDLISSYFKNKTLDWYKNNNK
VLYDDRIQSNELKLVIKNTTHDDSGIYTCNLRINKDSINYDIKRNYNVVVL
>FMHLFHII_00004 hypothetical protein
METISDGIIKVKTFNDDYFNNVKKIIMDMIKYKNIIWEESKVFDHEKGIEVINTNERQCK
QYIIRGLDDIFKVIRKKLLLSFEFPQKISDIILDNTITLIKYEKGDFFNTHRDFIHFKSK
NCYCYHLVLYLNNTSKGGNTNIHIKPNTIFSTKNDVLFDKTLNHSSDIITDGEKNIALIN
VVIKYNSNNDETIFKLPYLSENNHINFYEDEGNRKFCYCLVTVNNYSTEVDTFGLILNRS
GKCVLVNKYDDIITEKLIFENFDDMCMEISFSYNDIIFDYLKNEDGKNIAWKALNSSCDE
IWYPKSKNDFDFLKDLVKYVNNNLKDKINYYVLTGNCNSEIHYINFNVVRCYFSI
>FMHLFHII_00005 Soluble interferon gamma receptor B8
MGAVVFFAFLLFKLCYSFPKDIKLTSNDFNSKIEWTNDVSDSNYRVMIMTYSSGEWKQAC
NYTIQKYCNVSPFIDDNTDDFWIKFITVDNTESNVFTFKPICESVVITTPSVFIKRQDVN
TVLTINHPLAKDNNKNSPIYNNDKYCNIVFKYILSITFGDSNTIKYEVDEQFCDKKGCAI
EFGSQEKVCVTVFGNYETDYYQIRTNETSKACIDELTPRKVDTFLVKQKTDLSLLKRRIQ
KVTKNKFKGEKSFNKIVGIYNLVLSLFEYIVNELN
>FMHLFHII_00006 hypothetical protein
MYTKNKFKIFTKYITFLFSINEKKVKYFLNKVFYLSNYDYTKDDITKIVLKNSNKFTFTM
IKVISEYVLNENDYKKVIKELKIDGEYYADFYPFIKSKSFKHINSMKKVNFNDMMENYFM
VRKMKNTKKIGKIYAEFLTYDAMAVNHYGVEYINKIISKLRLSKTRYCFSLYEKNENNVI
DITTMKYIIGLISIISSHDTCKYPSFYIFFDEISHFKRKEFEKYICDRFP
>FMHLFHII_00007 hypothetical protein
MEGSDNTNTHCWICKDEYNVSTNFCNCKNEFKIVHKNCLEEWINFSHNTKCKICNGKYNI
KKNKKSCLRWKCSFMYCNVPAICVSLICLLLLPLTILLVKFNLKSMLENIENRDLIALIS
AMAYSLPCVVGFITVVHILIALYDYYLAAKSDNTTYQVYEYI
>FMHLFHII_00008 hypothetical protein
MNYTLSTVSSATMYNSSSNITTIATTIISTILSTISTNQNNVTTPSTYENTTTISNYTTA
YNTTYYSDDYDDYEVSIVDIPHCDDGVDTTSFGLITLYSTIFFLGLFGNIIVLTVLRKYK
IKTIQDMFLLNLTLSDLIFVLVFPFNLYDSIAKQWSLGDCLCKFKAMFYFVGFYNSMSFI
TLMSIDRYLAVVHPVKSMPIRTKRYGIVLSMVVWIVSTIESFPIMLFYETKKVYGITYCH
VFYNDNAKIWKLFINFEINIFGMIIPLTILLYCYYKILNTLKTSQTKNKKAIKMVFLIVI
CSVLFLLPFSVTVFVSSLYLLNVFSGCTALRFVNLAVHVAEIVSLCHCFINPLIYAFCSR
EFTKKLLRLRSTSSAGSISIG
>FMHLFHII_00009 hypothetical protein
MEKEKLCSDYDNDFTDYLFYRYCNPLFYYVEQDDINGVKKWIKFVNDCNDLYETPLFSCV
EKDKVNVEILKFLIENGSDINFKTRDNNLSALAHYLSFNKNVEPEIVKILIDSGSSVTEE
DENGKNLLHMYMCNFNVRINVIKLLIDSGVNFLQKDFDNNNILYSYILFHSDKKIFDYLT
SLGIDIDETNTSGYNCKDLIKFRNLTFFDKQ
>FMHLFHII_00010 hypothetical protein
MEKVTTFIFYLLIINVKILAFTKLSFGCLQSVMKTFENNSEIVKCPYVDTLNYNTTVKWF
LVNYNKYVKTGDVKKSFHEFKNTDRVYSVGHSLWINNITKNDSGIYACNVHNSTYYFTSS
VMLDVYKKETINSVIGTNYELLCINTKNFINTFNCSYEVNWFKDREKINNNFKYKKSKEK
LLIRNISKSDEGVYLCSITTDTRCNPKNLALKRYYHNNVIKKRFKDDINLTVNFLNSTIA
LGKNFLMECIGESKNIQRVYGSSIFWLINGVNVLDYDRSKNIYLGREMYVGNSYKIALII
KEVKRKYLSANFTCNLRNLEYNYLTKKIKYVNLKTLYKNEI
>FMHLFHII_00011 Protein K3
MSSNSDLAFCYVLPNINEVTDGIVFIKDNIVYVKLINYGLEALVIDYVNINMDQMNNIKK
TLVNKLINVQIIRMNKIKGYIDVKVYNNN
>FMHLFHII_00012 hypothetical protein
MISFKKVVICLTLFTTFYVVYSKCAKKRDLVIYFPHKEGENVLLQCKGYSHHSNYAYVYW
LIGNNNSFVEFMNGDIYKERMYFNKKPLKCGKEPRSDLIIKNVTEEIKNTNLTCVLMDLE
EPIKKTLILNDIWNCLNNTCEHKNGISEKKVSESESKNVIE
>FMHLFHII_00013 hypothetical protein
MEVKKIFFTVLLFYKIILMLSKENKNDYITILNKDIMMCDKSINFCLNGGTCYKTTFILS
YNKKPLMFCRCKLGYEGVRCHLRSLFHYF
>FMHLFHII_00014 hypothetical protein
MDTSNYNIEKVLNVYLRDLRIESLNNNELAILIMIRECCEVIKKDYKTEFNEICNFILHN
NVKSCYDINDVKNIIIETINSDFRPSVILASISLLSIIIKKKKSENNEVVNDDLALNELI
NTFSSYQKDIISFVEKNKKIDEQNDFIFSIINFFVMIGSIIITYYLLKIIGRIRWK
>FMHLFHII_00015 Deoxyuridine 5'-triphosphate nucleotidohydrolase
MDHSSSVVNCIRLSAFAKLPTKSTDFSAGYDLYSAYDYIVKSKERILVKTDISLSIPKKC
YGRIAPRSGLSLYYCIDIGGGVIDEDYRGNIGVIFINNGKNTFNIKRGDRVAQIIFEKVE
YPKIKEVKCLDGTNRDNNGFGSSGIL
>FMHLFHII_00016 Kelch repeat protein F3
MYISNDLTKLRVNELRPILKSSDLVVDAEDFVLNFIIKWGTVKKTNRLNTMKLVNDAVRF
TFLTEKGKKRLQAWSSRFKKKPYDFNKNSDKHIPRCNYKNKEFINSDKFTKSFKFKVYND
NLTKILFTNNIMDINIIDESVYDNELLYENNCNEIDENKTLNESIQQPSNLSKLSNIIDE
NFKFCTSIAIGNNIYFLGGVDKYLRSVNSVFAINVKTFERENLPSLIYPRKCPGATYFNN
RIYVIGGIYNNCIVNKVESWSFGESVWREEPNLLYPRYNPCVVNVNDTIYVIGGISEYDK
SVEVYNLKYNKWSLGECTKYSHYGGCAIYHHGLIYVVGGISYINNIKVFNMVESFNPMSC
KWRIESCLNQPRFNSSICIFDDCIMIVGGFHYERYIREIEIFDDKTKGWNVIGALDIDSV
F
>FMHLFHII_00017 hypothetical protein
MTLKRYINKEYVEELKYMLLKNDYDRILIFTIGGISQTRKDIFEISSNYFKKAIKKYSNE
VKLPFKYKPFTYVLEYINTGYITLNSKNVVDIFSISNVIEIKFIMDACTDFMINYIDDSN
CVDILEDLICMVVTMCTMLQINILKKGLCI
>FMHLFHII_00018 Ribonucleoside-diphosphate reductase small chain
MEPILKETSSRFVVFPILYKEIWVMYKKAVASFWTVDEVDLSKDLADWKKLNNEEQYFIK
NILAFFAASDGIVNENLAERFYSEVQWSEARCFYGFQIAMENIHSEMYSLLIDTYISSTK
EKEHLFNAIETMDFIKKKSEWARKWISNKKASFGERLIAFAAVEGIFFSGSFAAIFWLKK
RGLMPGLTFSNELISRDEGLHCDFACLIFKHLKYPPSNDIITIIINEAVSIEKEFLTNII
PVKLIGMNCVLMSQYIEFIADRLLLELGCDKVFMSTNPFDFMENISLEGKTNFFEKRVSE
YQKMGVISNKDDNVFSLDVDF
>FMHLFHII_00019 hypothetical protein
MHQMNLTTAMPNNNAFSIGTVLILMVLIIVIVISLYLLFQLVNCFYLFDLFNKIKVRMMK
LTTRRSFDELENVYYIDDKCVGVNVD
>FMHLFHII_00020 hypothetical protein
MDKKIYCGIVFGYRLLKKSIKEKAIKCVSFIRKSNMKTAISIERVTLLDGDGDGNGANDS
NSNSDSDTVSSDDNDTKYNYNYKYKFTKRKTPHKVMYYINYDDSVSNDDVFL
>FMHLFHII_00021 hypothetical protein
MSEKLKKVNKVVVNGKPYNSNSSNSTPSKDEIKKYGYCLNIKKPSSHNDKKETYLHNDYP
MVITTNTSFYDT
>FMHLFHII_00022 Protein F9
MENHFQVDTLYNLFIERYLQNLSLYSVPVNTTCGIHISEIKGTLKGCKLKIINLCIDDKE
LSFYLLIKTFKEFANTLSQNEKYELANEVGIDLDNQDKNYIPEIIRKCTSSAAVTNVIDI
QTFDIGECIAPNGKNILLQIINSGTSEANCVMNTIMKSMSNRYTINNYIDNRIPFINDVH
WFIFFVLIIFIIFLLGLCSIKRKINIKYKYGSFLYV
>FMHLFHII_00023 Serine/threonine-protein kinase 2
MVIMEIDDNSLECQWDNDEDIKSTTVLGDDIYFDYVISQLDIYQSWSPNVRLIRYFKKFT
KETLNKIAENEYINPSFFQQKDKRFYPINDDFYHISTGGYGIVFKIDKYVVKFVYEPNKQ
YSPIETTAEYTIPKFLFNNLKGDEKKLIVCAWAMGVNFKLTFLYNLYKRVLYMILLLIQT
MDDQKLSISNFSHKYFLKSFNEKKGDVKFVKLLSYFYPIVIQSNVNVINYFTHMFHFFEH
EKRSNYLYDRGNIIIFPLAKFSSDKVSEKMAIELGFKSLVEYIKFIFLQMALLYVKIYEL
PCCNNFLHVDLKPDNILIFDSDESIKISLNENTYIFNEPIKACLNDFDFSQVANIINKKI
KNNIKVEHNWYYDFHFFIHTLLKTYPEIETDKEFYNTLEEFIICCNKNTCDKFRLKISIL
HPISFLEKIISKKNIFSTWINGKPLSS
>FMHLFHII_00024 hypothetical protein
MSIMCLSNKKKEEYILKYFLNNRCYDDLYSVNGGNVAVGNFLKSKSEELYFSFNLFLNDL
DMSKKKVGFYSLKEINVNIFYKLLLNEEFFTVIGSYLVKLKHGNAFFLNESTFSNSVVIT
ACVKNKGISGLFIPDTTFLKINIEEGDFIMSGFLNGVNFLPQIGGESIYLVTILSPKELS
ITEKAFFYEKNNEETLNITSNIISIRRLKIIELVNKIIKLKKVMEKENNCYIPNNFVIYD
TILNKNNNFLYSFKKKYKIDDDETLWEKITNLFLKIDKLLDYNIKHYQLINDYIINKVKY
YY
>FMHLFHII_00025 Protein F12
MFKKQNNEFNIINALETYKHSIILARLGSGKGVIIYLNNLDLVRSVTKLSHLEIVGITKY
AEPYFIDMHMHKLFIDEVDTETFFSPKTSISPLVDIVKRRALENDKINKSVHKLHVFENK
NISLSEINYWMCDNGLSNYRFVNYKNSKKGNDYTLIDEMIIGCIGKHYIWVKQKKKYNRP
ELDILPYNVKSIASKKLWSKNNIYDEVVTIIPIIINSIITPLGPSIYMMTSFGKSFINFN
SKELILCFLKWLKETILINIKTAFLVGFLSNVFDFLLLKASWPKNIGWNFIGNDYIVSDD
GFKLILVDIANFSCKMEISDYFKQWNDKKKIIIPKDFITEEEAKCKIKALEKMALESVLV
LYDSINKQYDVLNNLIYPFNMFSFNRIEDIFLTKIIQTSLSKVNNFMYYPLEHDTVRFIM
QLIRFKNVKTVNYSPKKKIVIFKVKSILDIISLGRYPIGFPIYKRSIDINNNNLYIALCK
VSKNNNVKIPIIDDELETSVFFTPLTSIDIKLMRKIGGYKIKELGVLEWENSITFHNDDF
MKTIDHIKEILSDDIVDYIVNNNELLEHYENNTTLNNYLLLFKAFSISYCRFNIHSLIQK
IDSHFLGDYVLMYNYKEIYISDDFKKDKNALYEMIYDL
>FMHLFHII_00026 Envelope phospholipase F13
MWSLFFSKPPSGAGCRLVETLPKTSGITTQHMLTHECFDEIISQAKKNINIASFCCNLRT
SEHGKNILNKLKEAAASGIKVTILVDHQSGNKDEEELISNKIEYVKVKIGGDNDPGVLLG
SFWVSDYNKCYIGNASLTGGSISNIKTLGIYSTYAPLALDLQRRFETFKALNNNSSIFRG
IYITCCLPVSTKYHINNPIGGVFLSDSPDHILGYSRTLDADVVLSKINSAKKSIDLELLS
LVPVIREDLKTTFWPDIYNAIIGATINRGVKVRLLVGSWDKNDVYVMSSVKSLQSLCSNN
DLTVKIFHDTNNTKLMIIDNEFAHITPANFDGTHYLHYAFVSFNTNDNELVKMLSNIFER
DWSDKKNTVL
>FMHLFHII_00027 hypothetical protein
MFEFFLVFIGAIFALVGIVSIILDLVIMFKEINKDNNYKHIEEKQTLL
>FMHLFHII_00028 hypothetical protein
MNVNKLDEIIKLSPFRNMDRIKINKDDNCLLGNRCFVKMDTVKHFPTNSVATSDSVIIKG
YRFTLTELLYSPFHFQQPQCQYLLPSFVLKCIDEATKNKTICKYCIINKDDNSLNINIFV
PTFDLKYLIIGLRIKHFWSSKFQIE
>FMHLFHII_00029 hypothetical protein
MLKNAAIVTSLISLFDTSIDYQIKICRNYCNLIHSSIKIELKEVGYIDEKVISSKRWECI
SHDNKIDILVFYQKKQLSVSNDHLYNFLMRKRNKSLTIYYVKDNLLFDGITPSFRHINLD
SKINTRKKLKDLFVLINMNTCSDDIIKKFIYDNFETFKILMDAINCDSLWLRKALHPRKS
KKNIKEKNYYYNKFVNKIKDLDNIHYVNDICTSFKNITV
>FMHLFHII_00030 Phosphoprotein F17
MAAYNSQYYANTPFYITTKEGKYLVLKAIKVCDIRTVECDGDKASCILKVEKSNQTCDRP
SSPCERAARASSPNRGNNSVPFMRTNMLEDLQAKNRSVMSRILG
>FMHLFHII_00031 Poly(A) polymerase catalytic subunit
MNDKIVVDVLKLYLKRDPSLTEFHMLKSQYKNIQRVNIFNKEIFISLIKKNKKKFFSDIK
SSPSDIKRSILTYFSKQENTYSIGKLYTIIELQSILVTTYTDVLGILTTKGPDLFTSNIY
YNASSMQSLARDALNFMNVAQMTDKTMGRHNVSSLVDNVNSLMEEYLRRHNKNCICYGSY
SLHLLNPDVKYGDIDILQTNSRTFLIDLAFLIKFITGLNVVLLKVPYLKNYMVLKDQNDS
HIIDSFNIRQDTMQSIPKVLIDNIYIVDPTLQLMSMLKMFSQIDRLEDLAKNPEKLTVRL
ATLLEYVRVNYGINFISNQTKKNNMPMYSVIDIDKRIITVDTSNYDFPFKKCLVYLDESS
LSSDILDLNADDAIDFENVSNSAFLINNNILYTYFSNTILMKSKTDIHEISSRGLSAHIL
IYQILTKGDIIKPLTDIVNSLIGVEKNPIYDIIPRDKKSGKHGIIDIEKDIITH
>FMHLFHII_00032 Protein E2
MFNFLIPLKEAFILYNCDNLTESYKKVNIDDAMKMLINGINPNNLPQKWYFRIRKEFPSK
IYLFKPKTVPFVDLIALVYNQKNIELYREHINFHKKDIIKKCSKRIILKCIQYMVIADDD
IFCLIHRFSNIEVENILTKINSESIKNINYLFSESLAEKIFINDFSLCDSLYQHQSFESK
FLMDMLYKYGIIPNNDGILSVVSIELILDVLQSIKFHKDILTFLDMLTSEQLKDDRIKKF
IITKIKNGEVDQYKTYAIEFLYDKKDELGLYYSFFFKDPLIDFTKYELTKDFLKICCKYI
DNYDYNNKMYIINYLIEKNYINLLSTIIDKIPLNILTEELCIKIVCESNIKVKIKDIPIH
SSLVMIVCIEMGYEDLVELLDTIDINVLLEKNANLVSDYTFSTDWYNKNNKLIDIFVQKY
GFCSHKMNKLMFDYPLNKTSTMYLLNIFSSNNINKYFSYKIQPSLFYLSCTHSESNVNFI
LKKVSDIKNLIPFKKLPNKNSMFIYDQNKIKSLILYSNIPEIDMTVFKNMSYIEDSTGIK
IQINKENDIILKTEEDILNQVFTIAKLTTYGLVYLPYRYFPSWVPIIDIIKGSKYSHPSK
IEHGVIFKISPVDFIEYKFLGNYITNIYSLNEPISNFHSIINSFIQILFLYLVVGSTYSS
RGTNVFISLLISNFFTGMKINETLTEDISSVCKELNLFKKYICDSGFVIIKKNYLKNTLL
FCEKVCIFIILNKQK
>FMHLFHII_00033 Protein E3
MKKKNFLVLNTTKIKMYSCDEVDSYELVKKMVNNLSESEFITAIEISRKLNIEKSNVNKQ
LYKLHNDGFIFMIRSNPPKWFKKNGIDNDDNENNDTKKLNKSFSDTIPYYKIVLWKEKNP
CSAINEYCQFTSRDWYINISSCGNGRKPMFLASVIISGIKFFPEIGNTKKEAKQKSTKRT
IDFLINTSIIKF
>FMHLFHII_00034 hypothetical protein
MDDDNTNSYSDNTTPTYQDIEDIIYKYVKEKSKVKEILKWATDKASKFYIRNIINTKSNI
EETKFEPRNNIGIEYSKDSKNKLSYRNKPLIETNKDYSDICDLIRTTNGTEKEILRYILF
GIKCVQKNVEFNIDNIRDINHEEYFNVLDKKYNLPCPECKSKNTIPVMIQTRAADEPPLV
MHSCRDCKKNFKPPKFRAVEK
>FMHLFHII_00035 hypothetical protein
MENITPPNHFEKASVYACRLFKQFYNEKKYDLDECFLKVRNSMSRYYSMVGDDLVWNREI
LSYLYEYIAYKNNANNPNFVLSSKIVNLTKKNTKKIKNEINSVVQTYKLDKHIKKVNITH
YDYIKIKKTYDTFKKNVDIKSNDISVTLLKIYKQLSLISDVSINTRSMTKSLMYYMFPDL
FKKDKRHVFYRVDAKKGYCVLSSKKINLIRVLLEYKFDIKYKEWGLIKRYINTICNKGSK
SSKICIGKYPYLKLKPVSKIKFNYRSKYVSDFKRIVSSSFSLVDLTEKITKKTFSNIFRN
EISHLYKFNAEKNHLALDEYKKMRMCNKIISAIDYPNKDHIYSAIIETVNNYLDNPPKKL
GYNIDTCLTIAKNN
>FMHLFHII_00036 Protein E6
MDFIRRKYLIYTIENKVDFLKDEVLTKISNFTLNHILAIKYLILNFPRDVISKDVLSNPN
FYVFLHMVKCDDIYETVLKHSFDIPTLYIKALIKNYPLFNNTIERYKTLVSELFLDDKFI
EIVKYSSEFDNIIAVNYDLLLNPLFHNNEPIKNMEIIYSKLFKKSNFRKVKKMEVIRLMI
WAYLSKQDTGLDFTDFDSQDIYTLFQKSDKVIIHSDMTEKFKEYIFGSEKTSYWLWLNES
IFNDNVYNEGFAELMYDKILSFIYSEIKQGRVNKNMLKLVYIFENDEYIQSILLQIIYGI
PGDILSIIDVKDDNWKKYFIGFYKENFIDGKTFISAKTFNYDLFKVVAKINPEYFDPDKI
ISIFDHKPEKVKYFDTIDINNTFISNIIYETNELNLSTIEELQSCQIYNEETEYFIKEYN
TYLYLKEKDPYILYNGMLTNISKVPSNKKFSLFSKNILKYYIDGKLANIGLVLPNYKGDI
LVKILSHLKCVEDVTVFIKFSVCKNSSILPSIIRTILANFNISIIILFQKFLRENLFYVE
SFLEKTNHLTNNDKKYILEIITRGRS
>FMHLFHII_00037 Protein E8
MMGDIYSESQKRNDDQKTYFTRNLSPLMKNTYLYHNYSYGWIPETAIWSSRFANLDVTEF
YPITINLIKKFEFMLSLYDGPILPYEEKINTEFISRGSFSGRYINFLRNFSLLPTSEFIS
FLLLTSIPIYNILFWFKNTQFDIKKHTLFSEVYTNNDKHIELGKYFRQTGDYKPLFSRLK
DNNIYTLPFPINQSNINNPTLPIGFSKSDYETLSNLSAILYLTNYDPVLMFLVFYVPKIS
ITTKITPAVKYLMDKLNMNETDITLV
>FMHLFHII_00038 DNA polymerase
MEIKCINWFESKGNERFLFLKARNRQSETIFLRFNFYFYYAVTEDVYISLSPPAYSSDFL
GNMNLIDISERVSNHVTDVEKKKTNVNVWLIKEPQKRNIPKAIMEEFLNVSWFFISNNIS
PEGCYSINVEKLKKINEQCYHCDCPKECFATPINRFNINRSYLFLDIECQFDKKFPSVFT
NPVSHISCCYIDLTNLEFKFTLINEDILSNKDKKDATLKGYYKAKSVSDVDYTKEIIICS
EITMLKVAKKLLELTFDYVVTFNGNNFDLRYISNRLELLTSGKIIFKSPDKKEHVHLCIY
ERNLSSHKGVGGVANTTYHVNNNNGTTFFDLYTYIQKSEKLDSYKLDSISKNAFSCSVKL
KSENDNLLTFVGDNTTDDIGKISSFSEVLSTGNYITIVDDVFKIVDKSVGNDKFQLTILN
KNNTLKKNIDNDIYTISFGKDDVSLSDMYKNYDLNISIEMAKYCIHDACLCKYLWNYYGI
ETKIDAGAFTYILPQSMVFEYRASTLIKGPLLNLLLDEKIILSRSEKKNKYHYEGGKVFA
PKQKMFINNVLIFDYNSLYPNVCLFGNLSPETLVSVFVANNRLEAEINKQEIEKKYPPPR
YISIHCEPRCDDLISEIAVFDRNVEGIIPKLLKTFLTERARYKKKYKDATLSTDKSIYDS
MQYTYKIIANSVYGLMGFKNSVLYSYSSAKSCTAIGRKMIDYLNSVLNGSKVENGKVLLA
TKPINPFFEDGRNIDINIDTKLPTEYTFNFKSVYGDTDSIFLEMDTNDISKSIRVAKELE
KIINERILFSNFKIEFEAVYKNLIMQSKKKYTTLKYLPSFTNESIPERINKGTSETRRDV
SKFHKYMIRIYKTRLLQMLSGGNMSSVQVCVEILSSLESDLQIEFETKTAPLDMFLLSRT
HHCNYKSSDNPNMYLVNEYNKNNDEIIEIGERYYFAYICNKKEPWQKKLVNIKTYERIID
RSFKLKSTERIFYEVYFKRLATEIVNLLDNKVLSISFFEKMFGTRPIFYN
>FMHLFHII_00039 putative FAD-linked sulfhydryl oxidase E10
MNPKHWGRAIWTVIFIVITKTKTHKNLELCKKHIYTIIETLPCPMCRIHAIREIEKNNVM
SSDDLNYIYFFFISLFNNLASDEKYKIDLNKVLPL
>FMHLFHII_00040 Protein E11
MELVNIFLESDCGRVKIEVQNNTNECVCKKSSVVKSIDTFIDIIKQYINVEKSTFYLAIK
HQDIFIFKYDKGKISQIENEFFTFNSELMFVNNYNKITGIEFIVTDTMSMHIYPKVGLSV
ISSSNNNKFY
>FMHLFHII_00041 hypothetical protein
MSSSYIYPKRARDALSKIISSSITIERFLNSNVFVDTILEFGFHGILPVSLYNRAIDFDI
NNLKYFPVESIRLDDLINLLLESNTIDSKLHNAVLTYRKDLITSRNGDKLIKLMIENDLL
NIDDINYIVSECIVPNSYILKLNPMLVSNAMILSKDELIEVIKFTPSYTWKYLYKHLSIE
LDTLLYISDALNVPPTNISLLKLNNMKKAIEIIKKYPNDDIITYVSSDIKLNLSFIEKIH
EIVNDNFPRMLTHMNDFLFSTVSKEELIKRYGIKSVAMFSFNLELHPETISDDDKNFILE
NINIYESKCKNFFDFKKKFFYNQLKLYKPPSIIKSPSFKKNNNIDDEEKTIDDVLNYIDN
SKRKILITEVEFLISPFKFNPCIVRNICLSNSSIKTKLLLLKIIKKWKYSYNLTNKFLFG
IQSFKKINDIITFDMTNYITSVILCKYKKIYDRIKTLENLVNMNLICNCENCNNSKINHK
SKNIYLGKKTSDDDIINCLYDLVNYAIHGLVNPSLIGIKGWGALICLLNGTKKNKIDINI
YNTMDFNFVSTNGDILLSGSYLVNKLIPITKTPLSSFVPFTCFSLNDYFSKTVILFNIIL
EYMISFVLYRIITIQRYNNLKEYISKVVNTCLEASGVFFAQINISNIIETEINEIVINGS
FPVRLLNIFLKVITTILEEINGIS
>FMHLFHII_00042 Telomere-binding protein I1
MADNDDQLVLNSISARALKIFFTSKINDIVDELVTKKYPQKKKSLAKRIETRIPIDLIRE
DFVKRFKLDNYKNGILSTLINSLVENNYFSKDGKLNDDAINELVINDIEKKILEKISKSS
SLYIDVSDVKILSSRLKKPASFFIFNKNRYVLENDKIEELINQLAKNNDITLDEKYSVKD
NVYILSDELLEVLKSRLFKCPQVKDNLISKTRLYDYFNRITKQEESKIYVILKDKKIADI
LGIDTIKIGSFIYTKHSMLMNSISSNVDRYSKKFQESFYEKISEFVKDNEKVNVSKVVEC
LITPNIVLDAKLTE
>FMHLFHII_00043 hypothetical protein
MDKLYSAIFGVFMSSSDDDFNNFINVVKSVLNDDENYNKKTKKSFLRYYLIIGLVTIVFV
IIFIIFYLKVIK
>FMHLFHII_00044 Protein I3
MRKSIQKSAVVKKETPAMSTQSDEKKYSKCHEVIEYLKTLSKSKEKCVESVILSQSQYPS
CSSIMINLTEALSSKMTSTYIAVEGEAKIYKNKKDVKLGEQYFLKIKLSATSPILYQLLE
NIYTNIKEGKKVPPSLVNISINDLDEKTLNKGCLYINKMNGAIIEYKVPGNRSIVQSMIE
ELESLSKRDKQMAKAIIVPIVLYKNSETIKVTFALKKLIMERDFSANIVDVDGKSEKFSM
AEVSEEDSVRGLGVIELEDECLEEDDNNPTSTLFNV
>FMHLFHII_00045 Protein I5
MALSTRETFSLITVTLLAIFMIVSGSALLFKSFAPHRFMMARSLTFDKILSFLEYAAIFI
FVPGTVSLYSAYIKTLFK
>FMHLFHII_00046 Telomere-binding protein I6
MNNFIKQVSYKILKPNKKLSKKLDDEIKLKECIISFNFENFYYSNEILFNKPTNSLDDVN
KSWLIMESFKYEKYVIMGLINILKKKSYITDFFFIPIGWIVGNNINNDDNINNNHVVIKI
TIENNKPFQPLSNKIKDFLSHYDIFDLLIIQKEKELNILSFKTPNNFPSVVISLFPFDVT
SIIIVLFFGIFDDSYCGLSYITNKDNLNYVIEVLKPISSEINILSDEITRFVSIKLFNNE
LNKNKKFPEEKIFFICEFIKIFEKTKFEEPKSVIQTNITTFIPKKMISLIDLPSNVEIRT
LSKNGIDYITHINDKKLSTILIITKDNFFKNVSFSGTFKKENIIWKGYYTYRIIESTFDV
PKLKISPNGKKRYITCKSAFNNSTFTTRSGQYIV
>FMHLFHII_00047 Core protease I7
MDRYTDLVVNKIPELGFTNLLSYIYSESGLCFNLDISKFLTNCNGYVVEKYDKSVTAGKE
SCIPLFLLLELVDLKYLENNYQKDKDNVINNNEYELSLKKYLVNQLKNKYKNIQEIFNFP
TSIPIEYFFKPKLKEKISKAIDFSQMDIKVDDLSKKGFLAGENSKIVKIKIEPDKRAWMS
NKSIQSLVSQFSYGTDVDYLGQYDMRFLNNVPIYEKFDFFINKHILSYILKDKIRKSKYR
YAMFGFCYLSHWKCVIFDKEKLVVCFYDSGGNIPSEFHHYDNFYFYSFSDGFNTNDKDDS
VLENGNGDVDVLFRFFKYSFGAKVGCINVEVNQLLESECGMFISIFMIICTQTPPKGFKS
IRKIYTFFKFLADKKMTLFKSILFNIGEINIETEYLECPALKEYKRMEAWTKKAITALYN
KIVIKANKIVNNE
>FMHLFHII_00048 RNA helicase NPH-II
MDKLPNIYYFPNCVNLFPYQYSQNEFENMSNEEKKNFSFAIFPLIKHRWKKSYVVKDNKT
YKLSNEVNKTLKKVTNVNIPSIYPTKIDGASKEYTINNIKISFECYSYLNYSKFDNIHSF
DEYILRGLLEGGNKLKIFSNNIGSTNSTIGIFNNTEPFFKIKLASLQPKSQQEIFKSWIS
HKPIILTGGTGVGKTSQVPKLILWFNYLFGGFKNLSNDYTYIEKPIVLSLPRITLVKLHS
KNLLNSLGFKSLNESPISLKFGSITKDLINLNQRNYGIVFSTHRITLSKLFDYGTIILDE
VHEHDQIGDIIISVTRKYINKIESLFLMTATLEDDIDRIKVFFESPIFVHIPGSTLFNIS
EVYIKNSVNIKNKFKYIEEEKKNMLNAIKKYTPPKNSSGIVFVSSITQCENYKKFLSKHI
PYDIHIIHGKVKNIEDILSDIYSTNNTSIIISTPYLESSVTINNVTHIYDSGRVYIPEPY
GGKEIFISKSMREQRKGRVGRVKPGTYIYFYDIAYLKPIKRIDSEFLHNYILYGKIFNLS
LPNDLFVQPSNLDFLNKVSTYIDSFCISDEKWTFIMSSYYVNILEYAKIYSKGGNDACAL
DIFERENVLNDDAFNAIKLLNMRAKIIKHRRYNKLYVLTCKLMFGVYFGKTFNIIHNRPL
FGYITMITDSTFITDD
>FMHLFHII_00049 Metalloendopeptidase G1
MIVLSNGVRIFIDELMNKDIYLGIASFGFENDIGNIIGIAHLLEHILITFDPSKFVANAS
TARSYMSFWCRSIKGKSKTIDAVETLISWFFDENKIKDTFSISKIKDHIKELENEYYFRN
EIFHCMDALSFLANGDLYNGGRISMLQNINNIDDMLSSRMHRIIGPNVVIFVKALDEYTL
SLLSKTFGKLPTCPLTIPYNNLPTIKGKFVMMPSPFYTVMVNIKPTLDNILSMISLYEMY
HLIDYETIGDQLYISISFINEDDFEKFIKGIYIIDFEAYKNITFNYGDDFLMNIYLSFPW
IQHDIYDYITEINCNISIILKSLEDNIYNSIASGNYVAIYPNFSNVIFNKNDSQMHKIIV
MDNNNFSINDIYNNTNTKSRIKLMKKQSQNEIYIKYDDVEFISYVNLALGFKNKIKKKND
GVQINHQFSSEDIKNILESETFLKYSKSKPATMYQYLLLSFFVSGNSIEDILLNRESVLK
PVKHFKNKIVFGKKSKYHIKTFSSFVCGLVKGINITNESLTNMMWVLKRKGLIYSLDFTK
LDKHLYYVFMFTIYPNSVVKYITTENIFKNHCLVISEKGIVEDFSSMKKDIVIKLI
>FMHLFHII_00050 Protein G3
MSVNQKNEENNVIKNINNTFPTSLNSMIFSKPESVALTKIDTYYDSLSGTVTVISNNKKY
VFNLYFDEDIRTLLPILLLSK
>FMHLFHII_00051 Late transcription elongation factor G2
MPFRDLILFHLSKFILTKNEESIKTTLSLCRGFDVDLEELMLSFLSKKYLKKLTNIEYNN
LLPELTISFPNDIVNELIKLRLYKFYKIIKPSLKLKNTMKGIVFIKNRNVYILHTNDELI
DFLFKEYDPYIYTYEIDKPDNLSGSKIILCGYDKVTFYTYLITKIVTNQTVDIVVTDKCI
ELLLQPQNKQLLKDLFNNSNDMINKILKKIFYSVIDGGGQTP
>FMHLFHII_00052 Glutaredoxin-2
MKKTLILFGKPLCGVCESISDAIKILEDEYDILRINILSFFSKNGQIKEFEIDEGVAFIN
NFFKYLSSEAASLFKYNPETGQMAYVNISKFFNLAVIDKSFIKKDKLKEEIENSPYGVWP
PPSITE
>FMHLFHII_00053 Putative nuclease G5
MGIKNLKTVLVEIGALHQIKNVQENIINGIFVDTMSFFVSIAHCVNNLDDLYESFMLYIS
QWKKQGKITLFVDRGVIPIKESLREKRRNASRNTSKKNVLEIEKLNNLIKNLNVDDMMYD
EIKTDLELKIKKLEFNNYLANHVQLKDALDNSLKLLGSDVTIIYCDGIDAEFVMCQEAKK
IAYMTEKWPLMISTDQDTLLFSSCDDLPKNIRTMNQIYSFIPCAKTRYLSKLVALTNGCD
YFQGLYGFSITAKSLKSIKLFDDFTIDNVIKSLIIRNYSRKETDRYINAEKIIHFINKYS
CLNESIYNEVPPESITVQEFIFSALYHKWKKFDDSLLKGISLCCSLICVLKPKKDIKRNE
ISKLCNIINNDSNKKSSLNNIKSVIDIFGYDLNKNKNIVYGISKLKKIMLCYDDLFYFNN
ENIIRNNLKKNGIINIS
>FMHLFHII_00054 DNA-directed RNA polymerase 7 kDa subunit
MVFQLVCSTCGRDISEERYALLIKEVNIKKVLSRVKNSCCRLKLSTQIEPQRNLTVQPLL
DIN
>FMHLFHII_00055 hypothetical protein
MDPATFIKNYAPKGAVIFINYEFSLTEYFNPSEDKHAAIYIGSDCTSNHVKMFLSCSKFD
EKMAIEASYKNGVRLVNIDDLIKGAISVKVLTLNDVISQYKMGLAADNAMSFLGMPYGFG
NDNIYCFKLVADSYKFLGVTLPTYNILGKQIFLSQSFVNNKQWKIVYSFSKPTN
>FMHLFHII_00056 Assembly protein G7
MIEPKQSSIYSIISKSIIKSVVKGLSVNNEYLENKSKHLCYCNNSSYKENIINSIYNCIE
KDISINDNNHLKDILNNLKAHSVYVYNIGEFWRLYNSLYRFTHSKSFFVTCMPTIVTTLA
TLITLVLSNKLLYAAEMVESIETYLFSSQKTPAQELADLLEMKYGLINLVQYKIFPIIMG
IKEPLIGTLSTPIFFAGSTSTTDYSVEVNKIMELPIKTDIIPNLYKFLSEKGINTSNNFA
EYVAGLKINEIVKNTCAQNDEDNNVKQVLKNNNENYSGKIIDLLKEAEKHSKGHVLDGAV
SSPITENAFISNQIPLSVTDMEKFTILEYLYIMRVMANNIKKKNGDNKTSGGIILNINSP
FKTITVPGLNSVK
>FMHLFHII_00057 Late transcription factor 1
MSLRIKIDKLRQIVAYFSEFSEEVSINVDSNSNLMYIFAALGGSVNIWAIIPLSASVFYD
GKNNQVFNIPVSKVKSCLCSFHNDAIIEIEPDIENNLIKLSSYHVVSVDCNKELMPIRTD
TTISLKIDQKKSYIFNFHKYEEKCCGRTVIHLELLLGFIKCINQYQHLSILFKNDNIILR
TPGNLDTFSREYSMTECSQELQKFSFKMAISSLNKLRGFKKRVNVFETRIVMDKDDNVLG
MLFSDRIPSFRINIFMAFHD
>FMHLFHII_00058 Myristoylated protein G9
MGSSFTVPEKIKISNRPKKETMEMRLNVDNMYEQIKTLNQINDELYIGIINEEKKKQLIK
QFPEFLFIESGPGNLHKVIRSKYNNDKKYCCKSMNLFSYWQDNNGNITDFYKPNSILSSC
DPDIQNSGFCDDTLLSWCDTATQSNSKLCYDWINSALNRNNSSSEKLINGLITTCSNNAN
TPICNIFLHCLRVKNTETFDNVIDYILYSQSDDFKRTYMKCSYPSNKIIKESLKFFEARE
CWDPNCSESNLNFLLTKNYKNLGLCKIDRCNISINNLFFDEGSSVRMSCDDESIKSKFPI
NKEKVILHNVDNSFQLKIHLLTILSLFVIWVLIVAI
>FMHLFHII_00059 Protein L1
MGAAASIQTTVNTLNEKISSKLEQTAEATAEAKCDIEIGSIVFRQNKGCNVTVKNLCSSK
AESQLDAILKAATETYDSLTPDQKAYVPGLMTAALNIQTSVNTVVKDFETYVKQKCTSKS
VIDNKLKIHNIFIDECAAPTGTTTNFEFINSGTSQGICAIKTLMDVTTKASTKFSPSQSS
GYGYQFYIIAAVVVILSMVFLYYVKKMLFTSTKDKIKIILANKPEVHWTSYLDTFFSNTP
TIIEK
>FMHLFHII_00060 Protein L2
MAEILTNKLKSIENENKYNEKLIECIIQEIEKQQYFILKPIVRFIIDVMIIVIVLNDLTI
RLLKRNYKILFSIVLLSILYDAFAHSDVSSDI
>FMHLFHII_00061 Protein L3
MNSNKQHKHYENDKKNKNFKKDSDTKYNCYHDDFISNRLMLHEKESLDLECNLVKINCIL
KQACKEETECWIELSSLVRSKKSIGFPLLRGYKSFSSGKILYFEQFKNTKVEKLVVTSSL
LHESILFQIAVILYSMHKREIYVDNFEFDIVDIPKTTFFISVNQIVFEICTDKLVILSLC
TRPYKVNLPQSCYLNFLHCLETTMRKSYETSNYFFEWLIKNHISLLSKDGTDLFKIRKRT
VTTNHINRFVEPGTIVLVYRDDMYISGITLTDVSISDNVRVLFSLDGGYILEIDDFNIQD
VFLANEYFIRSQLTSIII
>FMHLFHII_00062 Core protein VP8
MSLILENLIDEETIFYAGSITDYTEMELIIAGAKIKYPRSFLSIFNIIPRNMTKYEMDLV
QTENITGAVFTTAFNIKKNLGIVDEKLTIESIENYYLDPNNDVLTLMINNTSLDNVTTRK
KRSKRNKNPVLFRQGSIPLFFIFESRKKVEIYKENVDKASSDNSYMKIDDNIAVASKYAN
MSLLDVHSPSASMKLNGVYGFTYKNELRKLSSDKEIDEYSNKPLQEPVRLNDFIGLFDCV
KKNIPLTNIPIME
>FMHLFHII_00063 Protein L5
MEKNNSKNIYFTPVFIEPTIKHSLLQSYKYTYIIIFEIITVMVLLFLFFKSEIHMLFKFK
QQKVISPIDKFSKTTLYCKENKLFISGLPNTMYSKEALSLNRQPITYKYCNDLLQSINGS
QQVFINDILRK
>FMHLFHII_00064 Protein J1 
MDHSKYLLTIFLENDDSFFKYLSEQDDETAMSDIETIVTYLNFLLSLLIRSKDKLESIGY
YYEPLSEECKTLVDFSNMKNFRILFNKIPINILNKQITVNKGYLSDFVTTLMRLKKELFL
ESPEPITYIDPRKDPTFLNILSILHENN
>FMHLFHII_00065 Thymidine kinase
MDYGYIHLIIGPMFSGKSTELIRIVKRYQIAQYKCCVVKYLKDIRYGNSVYTHDNNHVSA
ISTTLLYDVVDKIMNFDIIGIDEGQFFKDIVSFSENMANMGKIIIIAALDSTFQRKEFND
ILKLIPLSEKVTKLNAVCMECYKDAAFSKRITKEKEIELIGGKEKYKSVCRKCYFLE
>FMHLFHII_00066 hypothetical protein
MGIRHELDILLVSENLALKNVELLKGDSYGCTINIKVNQQKKLDFIIILRPDWTEVRNVK
KINMVCNGVVIDTTLIKKSFYEEVYSSSVTVFQNTTVEFFSDTSKKYKEEYPIVNINTIK
RYYEIKDSKMTCINFESPISDYDQVNYLKDYINISDDYYLYDACDDCIISSDDDDDNDNA
DDDDEDDEVNDIEDDYE
>FMHLFHII_00067 Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase
MEAVSMDKPFMYFDEIDNELEYDPKTSEEKPKKLPYQGQLKLLLCELFFLSKLQRHGILD
GCTIVYVGSAPGTHIKYLRDHFLSMGLVIRWILIDGRQHDTILNGLRDVTLITKFVDESY
IRVLKKQLYQSKIVLISDVRSKRGGNEPSTFDLLSNYALQNIMVSILKPAASSLKWRCPF
PDQWVKDFYIPHGNEMLQPFAPKYSAEMRLISIYSGNPIKLRCITKDDSIKYEKKMFYFN
KIIRNRIIINFDYSNQEYDFYHMYNMLKTVYSNKDFSSIKSKVLFFHHSIFKFLKIPIFN
TEKINYEPTQRKILSKNIMFKNRNIKKSIRYNK
>FMHLFHII_00068 Protein J5
MLDEDIYSFCDKNENDIRCRCLNPDSSIIKIGEETRLPYYCWYEPCKRSDALIVKSLKKN
ISLCNISDCRVTLGNIKIKNGYIDVKNVCGTNSSFTNEYIRTKYLNQEIEEPIIHPIWLP
ISLFIITSLILIT
>FMHLFHII_00069 hypothetical protein
MAVISKVTYSLYNQEEINATDIFINHVKNDDDVGTVKDGRLGAMDGALCKTCGKTELQCF
GHWGKVRLYETHIIKPEYIGEVIRILNHICIRCGFLRSREPYIEDVTKMSSHALRKLKDK
ILSKKKSCWNSKCMQQYQKITFSKKKVCFVNKSDDITIPNALIYQKITSIYKRFWPLLEI
HQKPENLFYKNFFPVPPLIIRPAISFWIDSIPKETNELTYLLGMIVKYCNMNADEQVIQK
AIIEYDDIKIISNNTTSINLSYITSGKNNMIRSYIVARRKDQTARSVIGPDITLTINEVG
VPFYIRNTLTEKIFVNPFTTDEVQRLFTNNEIKFYFNKRLNQLTRIKQGKFIKNKIHMLP
GDWVEVPLKENTSIIFGRQPSLHRYNVIASTVKYIEGDTIKIPPGIANSQNADFDGDEEW
MILEQNPKAVIEQSILMYPTTLLKHDVNGSPVYGSIQDEIVAAYSLFRMENLTLDEVMNL
LGKYGINFSSNGKTVFSGKDILEFLINDKVNYPGILSNGRIVANDIISDFIVAMRGMSLA
GFISDYKSNVEGIEFIIKSSYVFKRYLSIYGFGVTFKELRPNSDFTNKLEAINSEKIELI
KNSYKKYLTDVKDGKILPLSKSMESDAVESMLSNLTNLNIKEIEEYMKTTLINNPDNNLL
KMAKAGYKVNPTELMYILGTYGQQRIDGEPTETRVMGRVLPYYLPDSKDPEGRGYILNSL
TQGLTGSQYYFSMLVARSQSTDIVCETSRTGTLARKIIKKMEDMVVDGYGQVIYGNILIK
YAANYTKISASVCKPIDLIFPRESMVWYFEISSIWEKIKDGFIYSQKQKISKKTLSPFNF
LVFLEPSDEKHAISSKDLYDMIQNVIDDVSEKYFFTISSIDFIKYVFLTHLNPSIIRITK
ETATTIFKKFYEKLNYSLGGGTPIGIIAAQVLSEKFTQQALSSFHTTEKSGAIKHKLGFN
EFNNLTNLSKNKTEIITLISEDIEKLQSVKINFEFVCLGELNPDIVLNNDNEKYIIDITI
NRIYIKRADITELVVEHMIERFVSFSVLVKEWGLETHIEDNNNIKFTILVKFIEPEELSL
NKFMMVLPGAANKGKISKFKIPISNYNYYDDHNKSRKMNKMTVELMNLKELGTFNLENVI
VYPGIWNTYDIFGIESARSYLCEALLNTYGEGFDYLYQPCDLLASLICMSYEPESVNKFK
FGVTSSLKKATFGDNKALLNAALHKKTEPVNDNSSCHFFSKVPKIGTGYYRYFVNLELLT
RLEKKLSVTISDRKVEELIEKSDEF
>FMHLFHII_00070 putative dual specificity protein phosphatase H1 
MDKKSLYENVLLKSTGSLPKAKAPTKMMRVTDYVYLGNYDDAINAISSNVNFKYILNLTT
EKYCFNDSRINIIHMPLIDDEKTNLNDHFDYVTNFLSKCDEEHYPVLVHCVAGVNRSGAM
IMAYLMSKRSKDIPAFIYFLYIYHSMREKRGAFIENPSFRKQLIDKYIINE
>FMHLFHII_00071 Protein H2
MDKTTLNVNGVELEYAREKENKTIQSAKTSTLCFFMLILGISILLLWFQVSDNSIFSELM
KYIRIKKSIRGWRPLVETKTNLESDRGKMLSMGRDEYFSFNCVDFGSYFVPIRLDRKTFL
PQAIRRGKGDGWMVQKADKIDVSAQQFCQYLIKHKSENIITCGTHMINEIGYSGYFTNSH
WCSDFHNLLN
>FMHLFHII_00072 Envelope protein H3
MADIPLYVIPIVGREISDVVPELKSDNDIFYKKVDTVKDFKNSDVNFFFKDKKDISLSYK
FLIWEKVEKSGGVENFTEYFSGLCNALCTKEAKSSIVKHFSLWKSYADADIKNSENKFIV
VIEDDNTLKDLITIHNIIIEMQEKNIDIFQLRETFHNSNSRILFNQENNNFMYSYTGGYD
FTLSAYVIRLSSAIKIINEIIKNKGISTSLSFEMYKLEKELKLNRQVLNDSSKYILHNTK
YLSKKRANEMKNGIWNRVGKWMAHRFPDFSYYVSHPLVSFFGIFDISIIGALIILFIIIM
IIFDLNSKLLWFLAGMLFTYII
>FMHLFHII_00073 RNA polymerase-associated transcription-specificity factor RAP94
METKESVLIEIIPKIKEYILNPNINPKSYSDFISNNKNIFIINLYNVSTITEEDIRLLYM
TIEQNLEVDDQTLISIFSYIGYKFEQNVKEEITSSLFINEYNTTTDEMTFNLYNLFFDNL
DVYLRQRRINVLVNDDLNGDIMINYKTSDLTSNFNKDIDPEVREIPFNMKDMISYVSKNI
DQFRFSKKYLDFAYLCRHIGIPISKKKLNMRYIYLYKVDGVSIPIVIKDFLDVKYVYLEE
TNKTYKNSFSEDNNSLIDWGNIIIPKIKNKHLYSYIFLSNFYLRDLFPKLIEEKEITFKD
LKNIKKIEVIEPKSLRGEVKIEFVPCEHQVKLIEALKVDTEYFTKVNNFATEYIYYENGL
AFCNICGMNVPNFNLDAADVVKNNVIVSTFNKSIFLSEPYSYFVHSQRFIFNIIMSFDNI
MKSQTWVMKYNINRIILNFLIEINSRRQKYEKKFSNEIKKGIFFLRLSANLFDIHVSSTE
LFYSSKILNLNYIVVLVIILNSSADFIVSYMNSKKKKVDESSLKYAISVIIYDFLLKTKI
CEKGFLDTIILFTDVYTSIMPEELDLHLQRIIIELRKLVSIERSLVAPNYDVEVKTLDSP
LAALKFFESYTLIVNNMPVIENKIKKRNIIAHPIPILNDTKEMWEQFKKITSDDELKVLI
RYNDTNATKLVIFPTHLKIEIERKKMIIALKNLFINNVLKYYYSIPSLYVFRFGDPFPFD
DELVDKYHVQSKVNCYNLLRYHLLPESDVFVYFSDSLNRDKLEYTFYRFLSRYVNDVSIW
IDENITKIRELYFFNFNN
>FMHLFHII_00074 Late transcription elongation factor H5
MSWSINLGNNGDNFKTLEEIRAHVRSTTENMDKVADEIFPSDVKIPTTSSSSKQKKPVVR
KKAVTTTKKSKKIKEKTPIEDHDDENDNDNDDENNDNNDNDDINNIEADDKNNDTNNSDT
EENENDDKKEDNKKSKKSTNDNNQHDDDVIDNSDLKIATESIIKGLKILNNKVSSVSTVL
EDVQAASINRQYSSLIKNIDLLKSLAECGKSQVIRKKVKNTKK
>FMHLFHII_00075 DNA topoisomerase 1B
MRGLFYNDGKLFTDKNLTTLVSFDNPTYEIIKRIRIPPHLTDVIVYEQTYEQSLTRLIFV
GSDSKGRRQYFYGKLHVKNRNSNRNKIFIKVFNVINKINEFIDNNIINEKDKNDVLFQSG
VFMLMETSFFIRMGKMCYLKENETVGLLTLKNKHISISNGKIVIKFIGKDKVPHTFIVHK
SNKLYKPLLKLFDKEFPDNFLFSKLSEQKIYKLMKKFKIRLKDLRTYGVNYTFLYNFWSN
VKSLNPIPSTKKLISTSIKQTAEIVGHSPSISKSAYIATTVIDFLIQDSNILETIKEKSF
EEFIELIVDYIVNRDTI
>FMHLFHII_00076 Late protein H7
MDERLKTISMTFFYGELTTTDIMVLKAHLLNIFPNDTIFSINEDNKFIIDFKYNDCLASG
YINQKIIPITPEKYNEYSSMIAKELTNYNIIIDDIKGHILSSKKLKRFIKFYKTNNNKQN
KKIINASKKLNIALNKGIDYDYIRHIN
>FMHLFHII_00077 mRNA-capping enzyme catalytic subunit
MDERDLENSLSDYINKIVEIYDEIPNPTLSNDVNHEVELVFIQPPIITLSNVYNISSVTE
SYILFTVTNKGECIKIRTKVPMSKIHGLDLKNLQLVDLIDDIIWEKKTLIKEKKIDKHCI
IRYSSEERHVFLDYKRYTSSIKLELVNLVQTKVKNIVVDFKIKYFLGSGAQAKSSLLHVL
NHPKSKPTPTLEFEIITREKKNSRDILLDELHILFKNIFMADPKNVFLPTVIFTSPVKTI
MLKKQEIHNIELDKLYITTKTDGVGTLIKINKNGIFCYFTHLNYIIKYNLLRKFDDTVIL
YGEAIKQNQKWFIYLIKLLKPELSNRFKERDFLIEKLTSDISDRIVFKTKKYEGPYETHS
EVIDLLSTYLPLQTEGVILFYSEGNKSKIDYKIKHDNTTDHMINAVYRYMSSEPVIFGDK
YTFIEFKKFSDERGFPKEHGTSKIILGDNIKYLNNIYCIEFKNIYNDVGLKNIVLPIKFI
SEFSFNGDFLKPRLDKTMKYFYKEYYGNQYQVVLEHIRDQELRINDIFDENKLSDLGKKY
VDDEFRLNPEVSYFTNKRTRGPLGILSNYIKTLLISLYCSKTFLDNPNKRKVLAVDFGNG
ADLEKYFYGEIALLVATDPDKDAISRCIERYNKLNSGIKSKYYKLDYIRETIRSSVYVSK
IREVFFFGKFDIVDWNFAIHYSFHPKHYSTIMRNLSELTAPGGNVLITTMDGDKLSYLSE
RKVFIIHKNLPSSENYMSVEKISDDKILVYNPSSMSKPMEEYIVKKSDIKRVFSEYGFVL
IDCVNFDTVINRSKKFINYVSKMEERQSTKNFFELNREALKYDNIDIEELLNYYVVYVFS
KR
>FMHLFHII_00078 Core protein D4
MESEIKRLTNIIKERNIICPIDIEKIYNEKFLLLEKGLDETLYAIHIYDSMARFDNGTFF
KIAKFLYRNDIDVLKKIFIDEKKIESTNALLPTYSVNIIERKNALIPLTEIPNGSEGILL
ILLHLFNSFKFNKLTNISTIPYYLPFGKYINNIII
>FMHLFHII_00079 27 kDa core protein
MNICIIKNNEYPKTDLHDVTFFLLGNHKGFFENVLEKINKYKYFFSQYEVSSDNDGVLEL
KNVKSSHIIKDRYVTTREFILSGCQKEWCNEIIQKNDNITNYDTIIIQDITYFEKKIWKR
LLFVNCPEMKNSSYEIFLINPFVIKNNTDIFKNLILRSSINYFIFDNYAPLKKILTHIYP
SFNIEKTYIYINFNEINNIKIIKKCYHRNKIRAFVYAWFNFQICENSEIENEKVKKKYND
LYSLI
>FMHLFHII_00080 Uracil-DNA glycosylase
MKTIKTKSFPYCIEYHDDWEAVINQLVDLYDEIAEWILKDETSPIPENFFKQLRNPLNDK
LVCICGIDPYPRDATGVPFESPNFSKKTIKSIAETISNITGISNYKGYNLNNVKGVFPWN
YYLSCKIGETKSHSLHWKKISKLLLQHITKYVNILYCLGKTDFSNIKSIIEVPVTTIIGY
HPAARDRQFSKDKSFEAINILLEINGKEIIHWEEGFCY
>FMHLFHII_00081 Primase D5
MASHLVNNEYIFVLKKIGVHTSHRESEDPRFVDIFTCEELENYILKNPSCTLFETLRDEE
AYSVVRVFFDVDLDIVLDEIDYTAALEDFILNVTKFVSIFSSRECGTNQNIVLKCMRSNF
SLTKSTDTSRTSFHIVFPDTYTNMDTLIYMKKPLLEFLRSSENPLIRSIDPAVYRRKATL
RIVGTRKNPNNDKIHIRQPPHNNISDYLFTYVNMNEKSCYFTLSKKVDDKKADVLWEPNY
IHFNDAMKKVSKIIINEIVNINDFNVNNFTSIPIIIDYIMPCALCKKKIHKHHHQLTLGN
GILKIFKAGNPHSCKVKAIALEGNKLFTISQLIIDSNVIHLTERGDHVVWIKNSWKFNTD
EPLITKLILNMKDQLPSEYIPDILCPRKRKVIENNLKDMLVDTIETDTYPFMLPFKNGVL
DICSGKFYKGAESKKFICTVSTGFNLDIEQYLNEDSQEMKDLNNIINDIQPLTEENKENR
ELYERTLSSCLCGSTKQCLTFFFGETATGKSTTKKLLQSSIGELFIETGQTILTDIIDKG
PNPFISNMHLKRSVFCSELPDFSCSGSKKIKADNIKKLTEPCIVGRPCFSNRIHNKNHAS
IIIDTNYKPVFDKVDNALMRRIALVKFRTHFSQYSNSDSVKNNAAYDDVKPLDENLDMKI
QKNYFRYAFLNLLVKWYQKYHIPTMRLFPTPEAIPDFVFQLRVGSLLIPSSSTHLKFMSS
LSKIGYVLENDLMVLPLQLFQQKISKHFNIKVYGNDIESFITKHKKFANVSEEYLEYIFI
EDIISK
>FMHLFHII_00082 Early transcription factor 70 kDa subunit
MNLGIIKLFNNHVNSIPNILPHQLATLDYLVRSIIDENKSVLLFHIMGSGKTIIALLFAL
VASKFKKVYILVPNINILKIFNYSMDVAINLFNSDFILENIFIYSTTSFYSLNYNDNVIN
YNGLSRYNNAIFIIDEAHNIFGNNTGELMTVIKNKNKIPFLLLSGSPITNTPITLSNIIS
LMSDEEINFGDIIVQGKKVFQILLNEHGVNVLKNILRGRISYYEMPDSDLPMIKYHGKNF
LDTRVVYCNMSKLQEKDYINVRKLCNNEMFEKNMNNVSLAVLGQLNLINNLDILFQEQDK
ELYPNLKISNGILYGDELINLNISSKFKYFIDKITSLKGKHFIYFSNSTYGGLVIKYIML
SNGYSEYNGSQGTNPKLINGKPKMFTIVTSKMKSSLEDLLSVYNSPTNDDGSQIMFLFSS
NIMSESYTLKEVRNIWFMTIPDTFSQYNQILGRSIRKFSYNNITEPVNVYLLATVYSDFD
DDITSLDDYSLDEINTLPFDIKKLLYLKFKTKETNRIYSILESISENYTKEPHPYIIEIV
LGEIIRQFFYHHSRIKFDNKQLIKEISSVLQNIELVKKYIDDIVNGHFFVSNKVFDKSLL
YRYNDEIITVPFKLSYEPFVWGVNFRKEHNLVSSP
>FMHLFHII_00083 DNA-directed RNA polymerase 18 kDa subunit
MSTFIKNVYLPINLNPHELTLDIKKNIKDAIYKEYLHRESGGIMAKKIDICFDKELPLGE
IINNHIMVKVPCIVTYKYYKNGDIVSGTLNIEDESNITVLCGDLVCKLNRDSGSVSFNDS
KYCFVRNGIAYDNGSMVTVILKEEQQGMNSNFVFLASIMDPSN
>FMHLFHII_00084 mRNA-decapping protein D9
MLTTMIETDRENVTIERVNEIPDEKNTHVFAICITSDGKPLIAARRNSFAFQEIMSQRVS
PTSILKVSKHLLKYMYNNEIKEIQRRLLKGSYLNVSQMTNNSFEELILLGGKINKSESIS
ECLQREIQEESDSNLTIKCFGNKCVKLTIFDKLFDKTYISYCTTCYITETISQAISSIIY
NVEIRELKSLLECSKNDKYHYLLFIYNTLVNSK
>FMHLFHII_00085 mRNA-decapping protein D10
MDNYYPSSLFNDIIKRNRKLSKTYILSSNNQKIYVTGFNNQSLDNVKKVSISIVMLTSDN
KFLACSRRHSFLFTEIIRSKNIFRKRRLFLKYSNFLKKNERIILSSELDIKLSSSDHEND
FSNIIFPGGVIRNEEDVIKCLSREIKEEVNIDSKDIFLDYRFFIHMLIEDLLTDRFYENI
LFFGKTFLTSNEIIHNFFSNKEIKSLVFFDSLYNGIEGDIIRFVLDISRLKCFGNKGYEL
YNKNTFKSLKSFF
>FMHLFHII_00086 Nucleoside triphosphatase I
MSSYHAAYIDYALRTTEKMPIEMVGPVNKIKLKSYQHFVARIFLGLDKMHSILLFHETGV
GKTITTVFILKHLKDFYTNWTIILLVKKALVDDPWMNTLMKYSPEIIKDCIFITYDDKNF
HNKFFTNIKTINVRSRICVIIDECHNFISKSLIKEDGKIRPTKSVYNYLVKNIAYHNHKL
ICLSATPIVNNVREFTMLVNLLRPKILQTQSLFENKKLVNERELINKLGGICSYIVNNEF
SIFEDVDGSDSFARKKVYMKYINMTPKQEFIYQKAKMLEIKSGISSFRIYRRMAATFSFD
VLPEKKDRNLDDFNKEVNTLYKDFENSIKGRYFSDKALDYFKKGEELKGDVNASDLSLYN
ELKEKSCKFTEVCLSILSSPGKCLVFEPFVNQSGIIILLLYFSVFKISYIEFSSRTKNTR
VQMVSKFNEEVNTDGTVIKVCVFSLSGGEGISFFSINDIFILDMTWNEASLRQIIGRAIR
LNSHVNTPKDRRYVNVHFIIARLSNGESTVDDDLLEIIRTKSKEFSQLFKVLKESSIEWI
YDHQKNFSPVDDESGWIPLISRSIDMNAKTKEIVKVVEGENIWFSTSKRLVNIHKGFKTN
DGKIFDAEGNFLQTMPENPIIKIQNNKLIYILPDD
>FMHLFHII_00087 mRNA-capping enzyme regulatory subunit
MDDVIKNIKEGIYILLPFYEHLPDLNLTLGKSPLPSLEYGTNYFLQLSRVNDLNRLPTDL
LSLFTHDLMIPETDLEKVYEILNIKSIKSYGKNIKADAVVADLSAKNKFFKKERDLIKSN
NYLNENNLYVSDYKMLTFEVFRPLFEMSVEKFCIIKLPTLFGRCIVDTLRVYCSLFKSVR
LFKCASDSWLKDSAIMVASEPYKKNFDSFMAEIKKTTKSSIWKDANNVQFNILEYPVDKE
FINKFLEFSTSVYESLYYVHSLLYSSMTSENKSIENEYQKKLVKILL
>FMHLFHII_00088 Scaffold protein D13
MNNTVINSLIGNDDNIKRHNVFGVDIQNPTLYMPQYITLNGVSSTGSCTQNVVSTFEIRD
QYITALSHLMLSIDLPEVKGIGKFGYVTYVGYKSIQHVSISCNNGTIWESSGEDLFYSCK
NNETALNNSGFCHELNSISTGLTNNDTIKESATIYVYIKTPFDMEKTFSSLKLSDSKVIV
TITFNPVSDIIIRDSTFDYESFVKDFIYVTELSFIGYMVKNIQTKESYIEIPRRVLGQIN
QSTAVISEINSVTSFSVYVKPYYGNTDNKFIAYPGYSQSERDFICVFVERLLEDLVVVSK
EPPNYFPESAEFIEVPPNGIVNIQDVDVFIKIDNVPCGMSIYYHSNILVFGTRKNSITYN
ISKKFSTITGSYSESTKRIMFSHISHSISITDVSIPVNLWSCQRNVYNGDNRSESSKNKD
LFINDPFIRGIDFKNKTDIISRMEVRFGNDVLYSETNPISKIYNDLLSNCVLGTRTLKFN
FTPHTFFKPTTIVSNTARGKDKLSVRVIFSSFDPNNPIYYVSKQIVLVCNDLYKVTNENG
INVIKITEE
>FMHLFHII_00089 Viral late gene transcription factor 2
MAKRVTLPDITISSPKSVAKSTKNECFSSILPKYYVPVADISIDTNSDNSYCWFCSQILI
IKPLCIETIKGNNVGAFCSTICRDSFASMVKSHIALREEPKVTLLPLVFYDNPKEVINII
NTLRNKEGVYGSCFYKEKDKSIHVSLRSLL
>FMHLFHII_00090 Viral late gene transcription factor 3
MNLNLKMCSGCFHNGIVSEQGYEFCIFCESVFQKYSKSVQKKSNFHVSNKLIHLRNVLRR
LLSNQCSGEIISELLDLMKKNQISSEDVDANFVSSFLKAHERINKKDYKLVFEIINQVKS
EKLNLTTEKINEVVEIFKHLVFFCQENTPSKTINYSFFLDKIFDITLVTKNLKPQTVKNY
TKNNSNQLIWENFLIYMKNKKKTANIIDFGHEYVFTDEKFTTCSLDI
>FMHLFHII_00091 Protein A2.5
MSWYLKYKVDLDKPQKCSKCLSNLFEFITEDEKTIKMVLESQPNKLSILKNFLTSCRNKD
FIYKILDKELQRVLK
>FMHLFHII_00092 Major core protein 4b
MESSKDIFLTSKVNLHTEYKNQTLSLVDNHVHTPITSLSCSICNSLSNFATSDDIISAGA
RQRSLPMKRRILSKDKTNETSSPCPNNKKEDTDTATVPIDEVASTNDWQVKLRKDGNMIA
RYLTDNKCNVSNFTIQDMLTIMRKLNIMRSNRNELFELLAHVKSSLTNSSMSVKSTHPLV
LIHSHAHPKIGEQLKELEKLYSPTKQEILLSTTRFQSIHFVDMSSSSDLAFHYRDNESTY
YIHPIFMSLFGVKLPALENTFVYGDSYSLLQQLYDYKKVNPDNYMLLVNRLTEEAPIVFT
GISDVISTEIQRANIHTMIKKLIMRMRMGIFYCSDEESIDPFLMKIIHTNCSEVMSDEEQ
IIASILSIVGFKPTLVSIPKPRFMNNYEMQLQSVPYIVINPMKMITTSNCPISINTGNIN
SLTFDGNTGRVVFAPPNIGYGYSNPLENHFNAFGNNFPTISNISSPVIVNGVLIFYVERR
QHRNTFGGECYTGYRSIINDSPIELSQEVVINGIMYKLKSAVCYKVGDNFFECHTNNTDI
FLKGHYSIIFTELGPWMYDPLSFFNKSSRDSRMMRSLKNQYRKTSNNNQLDESDFYEWLK
GEGASFFLSKQQMLMNHITMFDDDLLKMEEAMSLISRQCCMLIYSQDYDSYITAKNITEL
F
>FMHLFHII_00093 hypothetical protein
MDFMKKYTKDLETTVKNKKDEEIASTSNLINNTSVTLTDVDTMLKSKEHLYQQMMMNQLE
EKKTLKIKNIEIKNNSNKLNDQCSDKKQNDPLKKIKSISHDELVKELKDIKDKTKSLQDD
SDSLIKDIAVAKDTTFDAINSIMNDLKKRFNIDKLDDNNSK
>FMHLFHII_00094 DNA-directed RNA polymerase 19 kDa subunit
MAESDDIIDDYISDEDASDEFEEEEEEEESLETSDVPSLKQSNYKVGSSISINIEDTNQQ
NITNASIISSKISAIKKRYTRRISLFEITGIIAESYNLLQRGRMPLVLNLSDDTMKQKIL
HIVIEEIKEGTCPIIIEKNGELLSVTDFDKKGLYNHLDYIINIWKKQNRF
>FMHLFHII_00095 Protein A6
MDKLRTLYYDFFNISKKYLEKETNALTSDPNFESDVSILMNLVPVLEKKISSTISVSTKD
EDIIVMMKYCNYKLFSFWFLKSDAVVKSVYNKLELENEKEKFKTIFKDMLINVQTLISIN
NMYINLKQDTAEIVSDSKKIIDIINQIKNTNCESSAYKLLQNNHSFIVKTINKILSDENY
LLKIIAVFDSKLVTDKSKLTEYREIFTISTESIIHGIKCISDLEISTIDVDNNKYIMFFK
KILGTVILFQNNDLNSQKFIYIVAKLYSLINQQFKTNPNVGYLLTDVLDSIKTKISIDDI
KQKGVNNLQSLIRFISDNKSSYKSILSEEYIKREGEIIEILQNISNESKIEYCGEIIDIR
KLIKITKDRFFKNDV
>FMHLFHII_00096 Early transcription factor 82 kDa subunit
MKYIVSPQLVLYVGKSQEIKRALYLTPYGVLDDKSPIYYFLTSCLKITTPEVLTRHILLT
LKMRQLKGYLCDLLSIDDDIIIYSHKNNLEYSYVDNTIFNPFVHTQRKTLIKSDGFLYNI
YPDACDFLVIWVANANDTSIPEFGSHEEVDNNILKFESRLLDVFPSMDLDMTVESKFNNI
FRTNLKFTGLKNIIKKVNELKECNYKSLLYKSDEFFINITGNKFILTDEKINLSVWDTDG
TLAFSSDGDTIMINNVKLFTSLLSDIDTQMERIKCDVTYKIFLSTPITSRIKLDIETSFI
FVETATNNILLSSDKRISIILAKNHISIKVKNYIPNIEKYFTFLVIAVNNMFNNIQQSSD
FTKVETVYWSRICQNTKNKHRKPVIVSSLEGDMKKISDNFYKSRTKEVFVNSNGIMFSCL
DPLGKYNNIGFLSIFHRLQKMCIPCCFLKDQSHTETFSSCVYQKDIISNVINPYILNFGK
VVTTSKISFLPIIFDTFFNDGLKIIFEQDNKRLKETSGYHVVKSCENENIKRIRTISDII
SFVNEDKNILISDDIVYFPMNYFDIGNKVYILIQEIVHEIVMVKKTLDKDIIEIFPPNYK
IIKDLFPRQTKSIIIRSDSGMDLTTDGFLIDGKEFNQDLSSNYVTFTKNITTSYKLHKYF
SPLLKYVVTESKDRFTKTWLINIMLKLGLDIEMDPSILTKLEKYYPNNGKSMTN
>FMHLFHII_00097 Intermediate transcription factor 3 small subunit
MFDPVPDLNLEANIEIGDVNIDKITSGEASESLSYASKSRRLFIHKTKDEERKLALRFFL
PRMYFLSYKEVNYLFRCIDAVKDVAITKKNNIIVAPYMILLIMDSKGYKLSESMIEVFFP
ELYNENSKKFKFTSQICSIQEKLGYNVTNYHTYDFESYYSTFALTLRKNTESDIIFNTRN
ESEFISSLSEVTYRFYIILLKNNLVQWSSSTGSVVNQMINTVLITIYEILKQKERDRKKY
ICHLANETKFPSVFLLDRMNLFDKIISDIKSTNSFKVSKRDKSILLTYFQ
>FMHLFHII_00098 Virion membrane protein A9
MLCYFTILKSIGGLALFQVANGAVDIFRHVFMYFCENNFRPNSFWFVILRSIFTMIMFLI
LGIVLLSISNNENKKEDD
>FMHLFHII_00099 Major core protein 4a precursor
MMPINAVTTLDQLEDSEYLFKVISSILPSLCLDYKVDENLKTSYVHPFDVLLHPDYGKIC
DENEIQNSIEKLGINYLLDVYSSNKLFHNVINPGYITPNDVVPKFDSSNNPIVNTHSFND
LPKFTRELLMYRLKYPEYNSRFVGGYVKPVEGGFDIQVEEKIHPDLNFENTYLLNLLYKD
VLSTSIQGFRVRKSNGVMFYRDFENLLGVRRVIDARSINKFDEEFKMFDAAIDHNTTLPP
FQRAMDTDILTMSMKHFIIYYQYFSNEYENSYVTFNGDYVLNSIPDLISIITSMRFQDQI
PKLIELYPDLTVQDYADLLLLDTATNNRYIHRLNNLNIKYVDISGRDHYYINLLNLLAKE
SRSRKLTSKLSLFWDGIDYQEYKSKKISDIIFYNATCYVMALFNKNGTTYCSMLSDVISS
NETPLRVCLLPRVLSGKTVSKLISEVLESVNSISKKDFPKRPASKLMHIGLSENSFMRFF
QLLRLITNKSPELSIKEVLMLYAGLKIDDNGSPHLIKKESYQDFSILLFSAMGFKVSIKK
SIIGSNNHTIISVRPRVSKQYIHNMLVKASCTKEEADKLISASYDLLHFMVSAGDYRNYQ
EYYYTKNFFPSYFFYGGNPQDSSLPQNVDEETTLIHISEPINILDRIDIRGIFSANTTDE
MMTVDAFGPENIVFKKNLENLIRDNKLSGDTLLQTMPLNILDKLITVAGSCNVSFNDLID
GISNENDDCDSTNDITELINTALKENYAKKNTSLVTQTFNSVASVSQKQFNDIKQTSCQM
AYIFKNLARSIYTIEKIFNAKLSDDVKVELLEKLKSFSHLSKSLYQDLISVETLKAILYI
IKRNGRTIDDVEIGSDEIRKSYEIIKPKIINMTNYYTEMSRAYFNFIKKNLNMDDKNLIT
FDIE
>FMHLFHII_00100 Protein A11
MTTIPVTDIPNDYSVTAFSEDGYPSNKNYEITTGQLSILRTVNDKLLAKTKSPSFTELEI
ANSPDFFIPGEDSPITIIEHVESPQTKFIDNSLKSEIVLAEKQRQQRVNIRVSGLETVIE
KEPIEEHMRITSIPSKTPSLGVMFDKDKRIKLLEDEIYELKTQQSKLLNTNNNLDNFTKL
LFGKNIHQSSEINKRIAIVNYASLTKSELTLEDLEICSEEEIDKIYKVVKQHNDSYKKRI
IVTHFITIIIIILEQILVKLGFEEMKGVSNELTSEIIDLNIGEDCEAIAVKIGIVNSPII
NIVIFLIKKLMTRIKLC
>FMHLFHII_00101 25 kDa core protein A12L
MSDKKLSRSSYDDYIETINKLTPQLRTILAHISGEQASQKSNLTPEDNTTNNTDENEVKA
GNVKTKACMTKPNKKSKSCSNKQTTSRSSNVCSSKSVNNGAVFKKRNTFNETDQIMQAVT
NGGKIVYGTMKEGKLEVQGMVGEINQDLLGIESVNAGRRNKNISQSKKKLIKRGMYKVET
ADDSIDDGMD
>FMHLFHII_00102 hypothetical protein
MIGDIFLVIICVVVIGLIVYGIYNKKTTTNQNHEAEKYEKMNELKTGYVDKLESKHLTSF
YKLFSSK
>FMHLFHII_00103 Virion membrane protein A14
MDIMGMISNYFSTALIGGIILLAASCIFAFVDFSKHKNNNGITVWRALSGIAFVLGIVMT
IGMLIYSAWGKYCSPNKVLIDGGRYNSSAIELNGQ
>FMHLFHII_00104 Core protein A15
MFVDDNTIIVYKKWPLCSVYDKKGFISFPTNNSCTFKKFNKINNDDSKTILLINPSLVEL
MLFCVYIKRTKWNGKIAIMFKRDNKLPPFRLVNDN
>FMHLFHII_00105 Virion membrane protein A16
MGGSVSVTNLNVSKDLADYNKKYMFINFNYPEYNKIITFLEEQKIYNDDKKSEILPNFCL
TDNLKISHCGNFVSDEISKKYILVKGDSCRSFSFRPGSMILYTNDITEDYLDNKIPESAK
EYILKGTQCKFIKKDYFINDDDIIKCCTNPSIGNCPKKLNNEYQTSHCDNAMSFFCKSNP
DNVQCLKWLRTKRKIALSTYTDICSNNMDKRYCSEFIRVVRPNFFTFGDISLLSYCNKNK
GNRNCWCVSPPNNITFDKYLGPRVCLLHECTDKTRDRKWLLYDQDIQRSRCKYIGCNINI
NSLTLENSKIDLISDCSKNKNIIGDLDPGIPKAKKKRDLPNIIGFPFIFICLAVLFYFLV
IYNRKKIKTNNINVRRR
>FMHLFHII_00106 Virion membrane protein A17 precursor
MSYLSYYNMFSDFTAGAGVSDNELFTREEEEAFLPKEHHEEGEEYKISKHHSLKNRFPNI
LMRSDIRALIGLILFVLAITTTPIIAVIMIAVASALLPFPSLVIAYCLSIQKFSGGVGNN
KQIIMSILCVSVSIITLIFRHISSTAYTISYIILAILFCVYAFNISKISYQDQDQACYKN
VKGGNKYREKPSFYEE
>FMHLFHII_00107 Transcript termination protein A18
MSMYYEIDYKLYSQIKRIIDDQQLFLFNDKKEFVEVEPKSMFKFILPIGLFSSESFPLPS
KIFAEKKNYIINLDAITLPNLYPLQKKVVFKVLSLMREKRLQGRPMYITLHLSCGFGKTI
TACYLMLRHKRKTVICLPNKMLASQWKTVIESTKLSYIISLDGVKKLMDKLKFENVDVLI
IINRHLSNEDFCKKIYSDYDTFILDESHMYNLMNNSILTRFLTFYPPKICYFLTATPRKY
NRLYCNEIVNILKITDMVKTIKVVEYFFENYSSVSIRKMLKRKLDNDKYHIYTEKILSED
SPRNELILKTIFENFKNDIIKRTIVVTKLRSHMMLLYSELNKILGNELVFLGDAKNKSSY
DVVKRIREKEKFIFVSTINYSGTGLDIPTLDSLILCNVVLNTIQVEQLFGRICRESDHQK
RIVFLFPTTSIKEIRHLVGFFTQKIISFSMEKLGFEKEIEGNDRGKKELALCKALNLQTH
>FMHLFHII_00108 Protein A19
MEDSAGNKRRKKRKPKTTVQDEECMTCSSCYSKLVKVSDITKVSLNEYKVGGKGNILTCS
ACGSELRMLNGFVN
>FMHLFHII_00109 hypothetical protein
MLLDNNKQKPLRCSEIKKANKNNYLSCENNDNDIVNFSRSCSNAYLNLFFTT
>FMHLFHII_00110 DNA polymerase processivity factor component A20
MTTESDLKNLKELLKLKKCINIADQKTREKYNSIVEWASNKFWKINTHKVIDAETSISDY
YNTSKNESFILKNGKYVFLPMCFGNIFIYFKGTMMELGSGNIQYIDIKIKKKIDKLLKEN
LDIEFLRFVYFKGEWILEDCFSKCKCPINFLKTASTNGLNTVPYILLNTKEIIFTEDDYE
NIDSYFTFYIKEPFKISSLCYIEEGNNERNIIDFYKKTYVFVESIKIENIHNNYYIPKIV
TKSKNVVLVRDINHLIDSKIKINSFISVKKKKYFLILDNNSIFSLETPSEAFCRIMKYIG
NEFYVNGKYLSKVSNDIEIKHLSSKLGLLSSTLSELITEISLCDKLSEKIKNQSVFEFVM
ECLEYPKADFLTLVNNMSFDVKNGIVLNFKLENINCLDNPNISAIYGNFNKFISLFNIFI
DVKQSLFKAY
>FMHLFHII_00111 Resolvase A22
MSNNHCLKHIKKEVICAFDIGAKNPARTVLEIESNNIKIIDISKLDWSCKWEEQVAKDLF
QHNYNYVLLERQSKRSPYIKFIHFIKGLLYNSDTKVISVSPVMVGYSYKDRKKKSTESFL
NWMKVFGLVNSIPKGKKIDDVADSFNIALRFVLDKWDINYIPYKKIKKIVKKPFKNNNG
>FMHLFHII_00112 Intermediate transcription factor 3 large subunit
MDELFTFLHKIENEYSRTIFNFHLISYKDKYKIYDIMKEKISIENIFNNIALTDEIKNHI
KKLVYCDIHLTKHIINNIVYPKYDNLNQNNNLKFSQFFDINKDDDCISLRTAEIFDNDKS
SLISYIKTTNKKKKVDYGEIKKTVHGNTKNYSNYFSGKKSDDYLVTTINTKESQPWIKTI
SKRMRIDIKKNAIITKGKSSILQTIEIVFVNRTCIKIFKDSTMHIILSKEKDEIGCVGII
NKIFQVYKILFCLLYDISKNENFKNAFDNSVSILNLTKFDDKIAKIKTVKNEYGFENFKI
GMFNLTYNKPILHTVFPSLLDYENKIKFFKGKKLNIVALRSLDECIQYVSLANKILKKMA
DRSDILNNLNIESESIEILKKILFN
>FMHLFHII_00113 DNA-directed RNA polymerase 133 kDa polypeptide
MDQRLGYKFLSPDPKIGVFYRPLHFQYKSYSNFINYRLQEILSVKRTLLSFKNDTEKIII
EIDNIKVTPPEYSPIIASIKGKSYDALVTFTVHIYKEVMTKDGTTITKISSYEGNDSHLI
KIPLLIGYGNKNPLDTAKYVVPNVIGGVFINKQSVEKVGINLVEKLTTWPKFRVIKPNAF
TFSFSSVSPAHILPTKYRHYKILMDLSQLDNCYISSTKTFITVNIILLVQYLSRVSLSFI
KHSLSYDMPSEISYLVNTIIESTKELIKTINDFDIDTYINDLIISEYNKQKSQLILEEFK
HEMINNFLPHMNDTPNQLKGFYIMSLLRKFIYCIYYTSRYPDRDSMVCHRVLTYGKYFEI
LAHDELENYIGNIRTDIINNHKNRGTYSVNIHVLTTPGFNHAFSGLLSGKFKKTDGSYRT
HSHYSWMQNISIPRSVGYYPDQVKISKMFSVRKYHPSQYAYFCPSDVPERGPQVGLVSQL
SVLTSITNICTNEYLELEKKICNYIRSYNHNDISYFETGYYITLENSLIACLNPNLVDDF
VIDFRRKKRMNYFGNLEIGITLVNDHMNEIRINIGGGRLIRPFLVIDNGNLIMDEIFSEL
EFKIDDMTFSDIQKEFPHVIEIVDIEQFTFSNVCESVQKFRALPKSEKCKYHLCDFPAEF
KDGYVASSLVGINHNSGPRAILGCAQAKQAISCLSSDIRNKIDNGIHLIYPERPIVISKA
LETSKIAVNCFGQHVTIALMSYKGINQEDGIIIKKQFVERGGLDIITAKKHQVEIPLENF
NNKERVKSTAYSKLESNGLVRLNAFLESGDAIARNISSRTLEDDFVQDNQISFDISDRYT
DMYQSRVERVQVDLTDKVKVRVLTMKERRPVLGDKFTSRTSQKGTVAYIADETELPYDEN
GIKPDVIINSTSIFSRKTVSMLIEVILTSAYASKPYNNDGQNRPICFPSSNETSIDTYLD
FAKRCHRDRYPSLSDDDINDKMFCDTILYDPETDKPYSSKIFMGPIYYLRLRHLTQDKAT
VRCRGKKTKLIRQANEGRRRGGGIKFGEMERDCLIAHGAANTITEVLKDSEEDYQDVYVC
ENCGDITAQIQGNKVCIRCSKQNLSTILTKVDTTHVAKVFITQMNARGVKVKLEFEKRNP
LFYKPLDVVDLSPNFL
>FMHLFHII_00114 hypothetical protein
MDRALSIFPGDDDETNERNINHREKTSGEHGHYEDKLLDLSEEEPNMIKIKNDIKKIINE
RYSNYISIDDDEISDILKDSFISNEEMQIKDFVLRLLVLEKLFQTSVKECNSLKNIIKRL
ENHIETIRKNMIVLTKKVDFQTGRSTTL
>FMHLFHII_00115 Envelope protein A28
MNAITIFFIILSTVAVCIIIFQLYSIYLNYDNIKEFNSAHSAFEFSKSVNTLSLDRTIKD
PNDDIYDPKQKWRCVKLDNDYVSVSMFGFKSNGSEIRKFKNLESCIDYTFSQSTHSDIKN
PCILQNGIKSKECIFLKSMF
>FMHLFHII_00116 DNA-directed RNA polymerase 35 kDa subunit
MFREEKVIVIDLNPDLATFIKHGFNNRVRWPLLTTGVVLSNNTTAVNEEWLTSIEHMPTR
KIFYNYTSKILRKEVGFCVYLKKSQTEKKRIITLGDFDYYIIDLENYKFIKIDKPIELNE
TLLHTFQDYRIKNLQVIEIIAFSSNIQITEKIIEGLTFINIETFNKEYDNIKPTLKTSFE
SIIPFIVTAPLGRLTFYVEHYPWIDFKSHMKEILDFLEGSLVSDVHSHKLETSVLDNSTS
SSYNPVSGMLFVNDLLTMTVVNFFGCNSRLNSYHRFDMTKLDINTFLKALADAFKKIANY
LEV
>FMHLFHII_00117 hypothetical protein
MSEEDIDESNFIHLITNLSTKSDCNDFTATLSTVKEIISQINLRVLSLNKKSKKNFKSEN
QQLSYVPRREGNRY
>FMHLFHII_00118 hypothetical protein
MNNFLNEAIKILSKCYIVDGKGTICKLLILIFIPSIDDNTE
>FMHLFHII_00119 Protein A32
MMNRFKEKHFLRNSLITNPFRIALVGGSGSGKTAYLLSLFSTLVEKYKHIFLFTPVYNSA
YDSYIWPDHVNRVTTPEELDYALITTKEKIEKYVETKGNKKADMFLLILDDLGDKQTKSS
CLLDFLNHGRHLNTSIILLCQTYKHVPINGRTSITHFCCCNVSDSDIENMLRSMSITGSK
KDLLKSVSLMRAVNVSKRRVLIIEDSVFSNGEQRICYDTADESVIRHIVDPSILLKQFSH
MKKNLTKILSSYEK
>FMHLFHII_00120 Protein A33
MLVDIPKSGTETDYDESNNFTAFAGSTIYGYGLKSKKNIKKKVKLINFCIKISIMTSMVS
LITITILLAFFNNTCELNQFKEHKPYFLKNPNPTTYSDDDTESELNVYRSCKGIVYSGYC
YTFNSEPKSFNDAYDDCEKKNSELPSNNLMNDWISDYLDGTWGEDGNVLFKEKNQELEAI
DISDEMRSYYCVRSFF
>FMHLFHII_00121 Protein A34
MKSLNRQTINKIKRASAPTAIFMLVSTIVSGIGTAIRYKDELFPSACNKGWVPYDDSCYL
DSRLQLSLYGGVMLCNKYNAKIPNVSIRHLKVISLTYGRQFWYGLVKKKNNIWVDVNSNS
TVDMNKNTELSNIKKSSKGDINACYVYNFGQFKNVSCNYVSYIICVKRLYN
>FMHLFHII_00122 Protein A35
MDFDFIFDKDEDDIYTLITTLGVLKIKKKEISKVCSELGINLIETLGPYNVVSLNIHPFP
NNFIEQSNLINCYISYNGTLFHCSKDERLSIPINGLYRGFYSNNSFIFSFDKENYGKLLI
DEKEQYFYLGTAYDIVNSNIIEVYNLYRKGDYNFIINPSDNFLEMIANQSKMCLTDKSGW
CIVDIKNEIEY
>FMHLFHII_00123 hypothetical protein
MINRINLSYGIVKYIKALLLKENISESDKSIIKTIINESIYPHNYVYNILDFNSLTINFN
TCEERNIIDFKDVNIKPQRFISYYKDYILESSEYMFIVCLKGETIIKCYNNNVISSNKVQ
KGEAFTLNIKTRYSTITKNRDLHLAIITYTTIYPLIYYKNIVFSKDSSLYNIFSGYKFAL
FRISSDDDKVLEDIIILNGRYYYSNSMEKVNIINIKTLLDKYNIKINSFTQIDYIPKSSH
KACVEALELSLDDVTVRQIYDGTSFKDVCSISGIKYKIVISYCVLCYN
>FMHLFHII_00124 hypothetical protein
MGIVSVVYVVVPFSFIVLLSYIFFEYKNVIKKMLFKKKGKNQKRTCVRLNSITYSTNSIE
STISESTWSNCSNDTFVKNEKENVEIVEIKRCDNELIEEGNNNVLENGCTTNTGEENLIW
DDNNVYDLPPNDLSCNNDCVYTLPDDNVSNIEEKITKLMHKNNSESNYYNCC
>FMHLFHII_00125 hypothetical protein
MKNKIFRSIPFFDIIKIKTQVLDLLCMNITKYYNEEHVNIIVKEIEQYINEKVFVKNLIS
IRCFNKEGCNKNRQNFNTSFSKALICIKSAKKGGVMVIFNKATKNKKVVYPSSNHIILLN
PLSYYTISQVNRGSVIMMVLDIDIPSMRIMYKSINNVKYSNVLALLCPFFKNEFVFALKQ
LIDINNNQVLCEQIVINREYYTVVSTNLKKFYIPSICFGKKIIDFNYGYDDFNEDIINKI
INSDTPFDFISPQKSIIDASLVYEKVIYGKINV
>FMHLFHII_00126 hypothetical protein
MFYFKKKKVNIIFLFLTIYINSSFSIPENKVSSINYSKCNKTIIIDCDINHFKYNGNVTI
NWFFNNYPLFKKNNTNTQTLILDFSKYLYGNYTCYVINNDNILLKETIQLKYIIKWLNEK
EINAVVILLSIYVILLWGKIIATTIKFKLSFKKDKKIIYLYYYIGFVITLIMLLGQYMIG
LNTNNIFIRILGTSFIQVSIFISIILQIIFFKKKFKNTLSLITVFLLHFISYIISLIMFT
MSLIGCYNEIYGKVIVYKLLLVIIFEFISLLSLFIFSLNTSIKYRKLHIIEDENLLFSIE
>FMHLFHII_00127 hypothetical protein
MKEVYTNFNISLNTTNQKIEVMGSVPTIDGKDPSIDIRIVSKPNKEKNNFDNTNENIFLD
DDNTNDYDENFIKPNKVSYDETKKGKGVDIEQTDNEKQLLSDFSDILNNDEKNHDKDKKK
VVA
>FMHLFHII_00128 hypothetical protein
MEELECMSIKITSENGSTISIYCESKTKISLDITTKKNNIKPITTKKSIKKIEKNDDDDL
CADQENAMEIDGEHTTDNNKL
>FMHLFHII_00129 hypothetical protein
MIRKYYEFNKTVSKAVCVLKGYKLHGVINFDQLQNGIVIISGVVLGLPEGNHGLHVHEFG
DETNGFLSMGNHYNPENKKHGSPFNNERHIGDLGNIYSNKYGISYIYILDGKISLVGDYS
IIGRSLVISEKNDDLGKGYNFKSFIDGNSGNGVAYGIIGIA
>FMHLFHII_00130 hypothetical protein
MYKINVFKNNESTIKCYHNNDIIFLSDDCVSFNSTTYNTTVFNNDDVKTELVTLCDVSKE
VQIFSLDNSYNGLFLTFLCNNNDSYWFVDILENGIGNNVPTCIDGEVNNKKVKSELQDSL
DKEKVLLSTFCKVSHGDCRMWFKKHIFYK
>FMHLFHII_00131 DNA ligase
MCTFKKFRSLCKSIALTPKYLEKTKLINNFISSLDVDNKYLVIKMLLPMVNKRVYYLNDL
QIIKIFSKIFKHDYKTMLEDLENGYVSNTIKKFFKISNTNIVPIQKSILLLNDVDMFLNH
LTTLTKEKDKQMFLTMISSICTADDLKCFILFIKNDLQIKAGVKCVLDALDKHAYNHFKN
SIDLKKIVFGISLNKLNDDNMVLFTPVKPMLADVCKSSYYAFKKYKDGICAEIKYDGERI
QIHKDNNLYKYFSRNLKPVLFHKIEGFDEFLTSAFPSANNFILDAELILIDLNTNKFVPF
GSLGINKKNLFKNSSTCLFVFDCLFYNNVSLISLPFVNRRKIIVDNINEIKNKVMVSEAF
YVYKEDDLNKIMDDVIKKKLEGLILKGINIDYVPGKRGWLKMKKDYLDDGSMADSADLVV
LGSYYGKGSKGGAPSIFLMGCYDKESNNWKTVTKCSGHDDDTLKKVQKEIEFLKISKDTK
KIPKWLIVDKIYYPDFVVCDPKKSQVWEISGSSFTKSIHHTADGISIRFPRFKKIRYDKN
WLSATSLNELKNLYKES
>FMHLFHII_00132 hypothetical protein
MRSHSSFELNTKRQDFDVLRKANAMALEQKINWTMLKEEVDDLFKKNCTDSDNTIYNGIL
SESITFEINHGFFNVDTEVSISKSLLYMDLGVENYTDVLESYNITISNMTTMATPTPATV
MTTPLYLENKNDTNDIKVKLYMVNSSIILTFENITIVINNTCIGTSINSIYAKITSDFIT
VNVTTDPLSTTPPFLTKSMFDNCTLTLPVTISQEGYYAKEYNEYTGTTESFTYSYYSEDN
MTESFTTAFSYYSDDTTTAEPFTTSNYLNDTTSEPSFTTSRYYLNNGTSNYKNISYVYNN
KTGIVFVKQQNNIFKNITIQTEFKNLCNESSLETKVYAVGVPEKFNTILKNISVEKSNDS
DSYFICKMIDDGGNCGIDIFMDAATNNINDELDSSKKGSSTRHARSVDHMELDPFCLHMY
HGIDETIDCSLKKNNKDTSGRSNRIRRSPPDKGKKPQVPAKGNLQLMSAEEMGARPKIRK
QTQDIQIGARGVDGPVSGSEEIYSQVRKELSQKLKSLVLDDNGKLTTTRLPKSTKALIGG
LVDSKIETSSAASDITRQIVHQQSGDIYSLPVKNKVFGVESNRKITSPIIDVDTSSNIYA
NVLQKRDFKVTSPKNVDVYEKTRTDSFSDDSYFLKRSFSSSSDDTYFLKETDDSDSDIFR
RSSKKDQTYSLAGKPLKKQSLRRYSSSDYETIGENIYESIREPEYALLSKPRVLNPRSHI
PLPSVPKDDIPFTQQKRKVIDMICDSRSASSICNARGLDSANYRGDGNIYETTDDDFVKR
ENSLYARSKLEPELKDNPLYESSSDSGIVSNPYNNPKLSRRNAIKKKVLNDGYEEFVIRT
DEEPNEKPNMAANTYNNNDKANNKDKNKGFSYLNNDIQKDEKNVNKIKKSKKGRTKRLTE
LSTDNKMNNMIKTIAISSYLSSTNSRISSIMAQANHQPKELTIVNIVTSVLSQIGGTLAM
AGSGSPKAAAAGLVIQGISGLIDAATSIYFLLSGQEQPKDPAIEKFSNYASYVSRTDAGA
RVCMMPDSDITITLAYRHSNMNVEAEKTRGEYTDIIPSTVYYLKNSQISYTVKVTLVCPI
GQLRLLEADINTYATLTREDKDGVKFYHVFGILELLSYHPNVTFTCGNEPGVIFIPFEQK
LSDMQLLRISTPGEPREAEAMSSDVCDIYPLKKFYVLAGNCPFDMSRKSVAYVTCSTLLR
MSTYEHEKQRWILMNPFSNGNEDNIQLFTFKKYDFSAEKDKIKLNSISHSDTICSQSDTS
TCFWADAMILEDVTSCNSRIRKLSVEMSTVSEKGYNNFVLTCPYGSTPFYISNGSIISIP
MNTRRTSVRFASKHNNVALISCIHNSNPAYKSDIVEVMFKQSNMSDMYLDFKYFKDRKYL
FDSFSDIMPKRSKTCKRASENSNCKNYYYIKHVPEIEFKVYVAKLPMVRLGTSYSGVLNY
QTLEKVNKYFSTPISISVDASTLSDVYKNQEHFWKFAMEKKRTFSSITATIFACSVVAGK
VNVNMGVKGSHDYYGRSGKYIYMGSKDFASNDKIYFKFIPDKAEYRLKDTYGECEIYLDL
KTRRVNVNCPELTIPQHPFDSPDVNSLCVLVATSRDHCAISEENWRSYDRTHGVGYSHEY
VDAEFDSCRKSHGPTYPVDNFCFYWCAGIYWPPDYDPCASSMVLGYSPIFPENRIVHPPY
IKEFGYEPGKNEYVKRELYNKLQNLYEKYNMLVLYSMNPVVEMSNGLAKSMTPEGREIFR
LIANSNEMQKAKEENDMKAEKVKMEIEETLNNIYVDTLSYSESTSLLRSAISTRCCVLDG
TSVYKYFDLEYYLCGNYSDYLININNVTYVKINDSLIEEDIYLVRNIPQVTCFHITLVAV
NNEEQQKKFETEIVTMAFEDVLTEIFDEYDDRMVSYFDKYISDDNNNKNSKFTTNNTIAI
ILSFVFTAIIILISTKLIMRSRKGKYTIHNNFVIFKNNNSSSEDDNTVSLSDLDLDNNSE
FLYF
>FMHLFHII_00133 Soluble interferon alpha/beta receptor B18
MLLLTSFVFSLLFSHSLGKRNLSYFDTDEYKNSIKDVYDFSKRLLDDDVLFALNDNCTFR
DERGKLATLKEPLSLKCPLLNEYGLKWPYMEKDDYKIKWEVVRNYTKKSINNNTNNYLIE
DGKLLILKTNLNTLNSKYLCTITRKRDNDCDQSIVQLSRYRNKNCYKLNGLKGRNIVIEC
GVRHVEYDTVEWYKQNKTSIIKLNNDSKRRIILRNITKGDSGKYYCKGHYSKLNISYTIS
RCTYLSVFPLSHYEYELVYMPTIINVTIGEPMTVNCSVRTKANAYEYIGAMWLDDKKLYV
GMEENLYQDGSRKIEGDDIIKTSHLVFVNVMEKDIGRTFTCEVGSYFKGEYRTVTLNLKS
>FMHLFHII_00134 hypothetical protein
MDNNIVDVDEYRMCFIYDKVDYINIDDPIKNIIEEYFLWRGLVGRIGRKPSKIGKLFVDF
INLDLTAKKMLGDLDLLFTDILKLDDINGANERLSNFVKFVNINFNNKPLVLLGLLGAVS
EFWGKKKISVNGIMSVFLSNISNDTLLEICNHI
>FMHLFHII_00135 hypothetical protein
MDIILGNTFSNNDWDISEFFKNVFENNVFENPKNICSVFDSIIIGNKTKSKIIVADTPKI
DLSISNTYKEKKKVDLIRVSRFCKAVALKSKKDYVYIPETKISFAILTVSTIDDDLKHEL
SCCSLQNKQYDLSMNMNSFAIVAKCNGLSIKGTNMLIVITFFEEKNYPHIPLIRTISSND
VFISRHSRLHKEIPNKDWFKFYVEFNHNYCTALTVIIDGSILYSRSDYKTHCIISKYQSK
KDEINDDCCCCYNTPSVYILNKKEIIEYVSCNTIRGGIHISLKGVGDFSSSYIGKCPNVE
HLKVVIGSTYDMLTKQDSISGKKMYCSYIYGIAHR
>FMHLFHII_00136 hypothetical protein
MNKINNIFKLIWISNYINVILSATCISKIYSSFKENTVKISCNKTSKFNSIIITWKKNNE
TIATYGPHGSYVVDDYKNKIEYISKSFNYSTIIIKNATIKDNSCYTCIFNILLSENDKGT
LCLNTTNDEYINNLIPIKINENNNHIKNNIIVDDYGTTESLFSLYGTLCLCLWIYMYYVD
TVRFFL
>FMHLFHII_00137 B1 kinase
MPKRNINVFEEGDVLVDSLKKEWRLGKIIGQGGFGFIFLAYSQNNEEYVVKIEPKSNGPL
FVEQVFYQRIGKRDMITLWSKNNHIDHLGIPVFYGFGFHKKNGIDYRFIIINRLGCDLNK
IIQYNNNKLPERSVFLIASKIIMILKYLHENGYTHSDIKASNIAIDINNKNKIYLLDYGL
SYRFMINGNHVEYKRDPKKMHNGTIEYTSIDMHKGVSPSRRGDLEILGYCIIKWLGGKLP
WENDLKNCKYVMESKIKYMNDIVNLMTDSLGPNYPEKILKYFNYIKTLQYDSIPDYEKIM
SFFLL
>FMHLFHII_00138 hypothetical protein
MDSDIRNGFILLNYEKVKVIIVLANNYVNITKLCKPMGKSFHNWWNLKSSYQIICNIAKE
EDIEVEDLSFNVWKGQETKDVHGKYIHPKLLVYILNWISEEYCAKILSIINDFNSKILNN
ITTNTKINKIYKRLPKEESMFNAIFNKENSKSKNYKKFLINIPTILSKYEKYFLESEEKE
CSVCLENVYDKEYDSMYFGILPNCDHVFCIECINIWKKENSTCPVCRDEFLFVIKSRFFP
>FMHLFHII_00139 Protein B5
MKNIHMLLILLCNKVYSLCDLNKCCYPPSIKNGYIYNKKTEYNIGSNVTFFCGNNTRGVS
YTLVGEKNIICEKDGKWNKEFPVCKIIRCRFPALQNGFVNGIPDSRKFYYESEVSFSCKP
GFVLIGTKYSVCGINSSWIPKVPICSRDNITYNKIYINKVNIDDNFFNQINNSNTYYFDK
ILQTNNVNRFTLIFFVVVSIKILFGFVFIFFSCNKKPLDSIKYYK
>FMHLFHII_00140 hypothetical protein
MGNKNDDIKHIIKEYIRWRGNGENICEERELNIFKKLKKMDSFVKKNIKESNNDEYDIIK
SMKLSLDDGPRMDKLPEYLLDGLNAEEILGLCGIISEKVVSATYEVDWDRVYESLFNILD
EKDLNYIKSKIM
>FMHLFHII_00141 hypothetical protein
MDERNSFWSLVKKITTENSQNIINQSYINPIRCIKSDDICQSYTSIVIKENDQNYIHKGI
FNNKEVIVRTFKKSHTSHKILMDISNNEIKNLRRIDSNNILKIYAFYIEMCDGLPRLSLI
LEYCKRGYLKNVIRKERDLTFKTKLDMAIDCSVGLYNVYKYTNNKPYGCISSVSFLVEEN
YKVKIICHGLEKILANPPFKNINAIVYQSHKMLSNVFNERTMDDDMYSFGVVLWEIFSGK
IPFKNLTTKEIYDLIINKNGQLKLPETPHLIKYTVEKCTSHTSKRPNIKEILYNFSLYKF
YN
>FMHLFHII_00142 Kelch repeat and BTB domain-containing protein A55
MYSFYELRKYCDVSICFNDVIKIKGHKIILSNSSKYFDTMFSNKYFIENQKNDISINISN
LDNPEVSINEIIKFMYNGKLDKTLKDYVILKDMLKIADYLIIDDIIPLCITSIVKIIDFN
NCLDACIFSEFYNLKKLNRFTYKFIRKNIRKIYLKKDFIYLSFNVIDLLLRDKKTVFYNE
DDVLCIILQWLNNEENNKYFHDVLKVIRFSLLSEECAIKLKIKYKYLFPDSLLSKSLFSS
KMSRRESTFGSFIYISDPNWYSKKYDIMYIRTFNYITKRVKTIDSIPFVEKFHSVLHNDV
IYFLRFEGSNNKNKFDRNFNSYDIVTKSWNSFPKIDDCENFSSCVLNNKMYLIGGEINGI
STNRVLWWDFKSNYWNQTTPMRFPKSESCVVPAENFIFVIGGKDMYSLDVVERFDTKTQS
WSTLMHLPIRLKRSSGIYHKGFIYIVGGISYASAELGIGYEGFVNKIYRYDISNNYWIEL
NPLRHTKINVNLGILDNDNKIYAIGGDKNNTIEVYNISTNTWSMFGRSFCNLINSKQCNI
FTKSVFL
>FMHLFHII_00143 hypothetical protein
MILLYDYITLTKSRNIKVKNIIKLIKNDQLIDFNYKLFTLCEYVSKKHIRIDVLKILFEI
GCKENLHRLSYYTLLSFFKNYKIKYNFNHVKSIIELITSYGVSFNDEPIKKDSYPILFLV
SNEKFNHISLYEYLENNNINFNIVRSDGYNLLHLYLESCNNIKLSVLKLLIKNNVNVNGL
TRFRNLTPLHIYLCKGYCLNYSVINFLIDTGSEINCGKETLLYSFFTTCDNEKVFKSLTT
KLIKKGADINQKSESGLTPLMGFVAYSDLATPNNIKFILSCGGNQLVVNPQSNETLLHIY
LRRYDVSLSTISTLLESGININSVNFKNYTPLHVYVDKNIEHLSLDVVDYLIYKGATTER
VNRYDCFAKTILEVFLEKNKFLNNSSRYFINYILKYFPINEKDLYGFTPLLSSVYVNNVN
FFNYFLRLGSSINVISEIGETCVSIPIENQYKRFLKIVLDSKPNIKTIKATLRYLSDKEF
NTRTKFKLMKHCIKYLFTLDPDEYKNHRFIFSKFKSVVNECQKDIITMKSTFLKTVSVYD
LIFNKNGTMHKRYLNTMEVRKYLKSNIYAERVRCVINNSIEKDKKIDSIIKKVNILCKHT
IWDILPEEIKDNIFNCMSLRDIRVIFHMFVVYKP
>FMHLFHII_00144 Envelope phospholipase F13
MKDCHEDTKLVIVETIPCDLDLLYNVSTYDFWMKLISETKESLYIASFYWSLYDEDSKKD
ETSNNGKMVLKELIKLTSRASLKIVVNKSNQTSEDLLILSSYGAQVIYVDIKNIFGGVLH
TKFLISDELHAYVGSANMDWRSLSQVKEIGIGIYNSSCLVMDLIKIFNEYCYIGYTNVPC
FWTNEYQLCYNIDNPLSLINSNYKMFIASSPPSLSKNNGTDDLYSLLSAIKNAEKFIYIS
VMNYIPVIYQNNKTLFWPDIDIELRRVAIDKKINIKLLVSFWDHTPLIMKGFLKSLKDIN
YKNINIEVRFFIIPKNQLNIPYTRVNHTKYMVTDKVAYVGTSNWSGNYFTDTCGVSLNII
DFNELSIRSKLENIFIRDWYSVYSFPISYVTPKDNNEKVPIKQDRDFLDYKL
>FMHLFHII_00145 Ankyrin repeat domain-containing protein M-T5
MSLLYEYVLHSPTVDKDAVELLIRTGFDVNEENCDNESILLLYLKRKDVSIDILRLLLEN
GADVNYRSYYDTSITSVIRNYELDSNTIKQIIILLLKFGADINLKPFNGVYTIMPFIYNF
HINNCNMFKFLLSKGIYVKNDIIDSRGFNLFHMYFESFSVKIDVIKILLSFNVGLFEKSF
KGLTPMNIYFDHFIDVISLKVIKYLISKGVNIETNNNGSKSLLETFLRSNKILSRKCFKV
LNFILKYVKLNKVDEKGLNPILISAKADNYDAFNHLLKLGDDIYNVSKKGNTVITYAIKR
ENIDILNRVLAIEPKKYLIKQTFEYFSNYGYGGINGLFLSERKSLMMILLMQYSFKVYPI
FYKNFYEVRLLFPNIIEMYNEDILLMEKEKVGKNISVYDLVFNREKETIPVKFLKNENFL
KFTSSTIYGERIKQIINNTYRYENCLNTSINILNKYCNKKNYWNYLPTEIKIHILEYLDF
SDFDTIINPKRKSKKYFL
>FMHLFHII_00146 Ankyrin repeat domain-containing protein M-T5
MEYISDYEELLKEIYINQSNLKINVLKKIINDIPTTYHKGIYNNLLLTVLGNKSISLSVQ
KYKKILSFLVDNGADLNTKIKYKYNALHYYLYSNSNVTVDIIKFLIKKGADITKKCNGDN
VLHTYLCNKNIDFKVIKFLVNKKIDLGDRNLDDHTPVNIYIRNKRNNCEIDTLKLLFLVD
FNIYNKEDIFLSALDVFLDYLKSYTRKSLDIVNYILENISINSVDSNGFNPILYATVSGQ
KVFFDYFLKLGCSINITTSCGETCGSLSLMDCDYCTFKTFLSKKPNLQTIENTLSCLSDY
LEDIYYCDLKFKMFKELLLEAFMLDSEFYNRHESIKLYFPKTISLYKEPIVQMCSDKIGD
KSVYDIIFKNSDIRYCYNDYINKYTNLKYYGNLIRKCILASKMRKKNIVKIIKTINIAPY
WNTLPTEIKMYIINFLSDNEIKLLAIK
>FMHLFHII_00147 Serine proteinase inhibitor 2
MDIFTHLSSIASPDSNVLISPVSISSILSILLFGSNGDTAIQISSVLESTYSNCCSDDII
IANRIYGDLKLHLKTQFIDKFGKELILVNFNHNTELIKNDINEWIKRLTHDKIKNLIDEI
SENTKLLLLNAVYFKLKWKSPFDKQQTKIEKFWYDNSRYENIEMMNDVNVYPFIELKELG
LKIIELPYENNYSMIILLPKDIKKIEKKLTGNNLTLWIDKMNLYEVNVKIPKFKIEETYD
LKLSLISLGIIDIFDGSADFSNMTKNKNLSVDNFYHKTYIEIDEEGAELSAASYCCVADC
GCNEKEFIANKPFIFFIKDNINVSFLFIGKFSFPHIR
>FMHLFHII_00148 hypothetical protein
MDTNTLPFSKHYIHDFTDYDNFEKKNSFSMSYQLTGILQYYFIWRFNGGKVDETTGKIFK
EFFKYDTLAKWRFSKRDFEQCKNMLLENDKNISYVLDVPKPEKNDPLLNLKELIGFLAIL
SEEIKKNTKFFALFNIMNSLFTHTKIDIVNCLKTELQFLYP
>FMHLFHII_00149 Kelch repeat and BTB domain-containing protein A55
MYAFYEQQRFCDVTLLFNNGKKSIKTHKIILSSCSDYFNVMFNNNFIENIIDEINIYIDI
ENDKSLDEVIKFMYLKKFNYGINNYKILKEMIFLANYFIMDNLVNLCIASIIKFVDVDNC
IEIYKFSQYYGYKKLSSYTYDYIRCYIESIYNQNEFTTLTINDIMKLLSDRKTIVASENS
VVEILVSWLTSQNSISCFEICKILKLIKIPFVTEEYFKKLQYHPKILYNEKCRKILRVKN
NNITPRASTLGSIIYISNPNDHSGGNPIFMAIYTYNFVTNEIKAIDNIQYANNFCSIFYN
NIFYFINFSYRVRDSLVHDDFQSYNIITKEWGKIPKISDRKDFSIIIFNEKLYAIGGIKN
GSVVSDVSFWDLKSSKWEDAPPLIFPKSNMSLANNNEYIFAIGGKNHELLNNVERFDINA
LKWDNVAPLPIPLYNSSAIAYKKYIYVIGGKTYIDLPERYNIDPVDGSSKNLFMYNIEYN
VWNELNMMIFTKVLPSLAIINNKIYVVGGDKNNLIEVYDIKKNYWYIFKKSFPKSLSKQE
NIFTNKVFL
>FMHLFHII_00150 Ankyrin repeat domain-containing protein M-T5
MDIDNIYNYIAFRGNPKLSIIKSCDPNKIVNEYSLFQKYLQRDSPSIDIVKLLINLGGNV
NGLENEYSTPLCTILSNIKKYKHMLDVVKILIENNADVNKKNSEGETPLYCLLSNGYIKN
NKEILLYMIQMGVETTLLSKDGYTMLQVYVKTNHHIIDIEIIKILLGSGIDINTISNKEK
YDTLDCYFKYNIDRIDANILKLFVDNGFIIKKEDKSHKKKLMEYLNSLLYENRRVKKNIL
DFIFTYINVNQVDELGFNPLYYSVSHNNRTIFEYIIQLGGNINCISELGDTLLFKAFENR
SLFIFNSILEKKPNKKTISYTYYKLRKHLLDVGDFINQIEFDIIKKFIAHVILYVKNFSV
RNRTKAFIYFDDFIEKCTKSSNYIHNTYINNETIFQLCFNKKYIPISVINNNEKLLKKHT
KLFYYGNILKKNIEKSKKYYENICKVSCCISNLCDTCSYWNTIPLEIKFKIVNNLSLNDI
EMFLKNNKK
>FMHLFHII_00151 hypothetical protein
MISYILSPLLSVFYFVIGKITNLVTFLFLKFFWAMIGLMNPYNMITSSTKNLFSFNINPF
RQKKKSFSFLSYINPFKKEEKKKGLFSSFFS
>FMHLFHII_00152 hypothetical protein
MSSLTLFIFFLQLFIFTSSVSGISIKRCTEEENNTWEIEVGLCIQTENFRAIKTGCYKIQ
GPGGLLTEGNGFKIFAHDDCSKEETQNNFILDSVNEAVYALGKYVYMEISTSNITTLYSL
PQCAKRISLSISCDQVTTEMKSYVESVSFKDYDLEFVITTDISCVKHVSSSVIVRNECEK
KYISTGKKIFGFNNKIDCSAVKFSEHVNYLKTCSVGKFDRKKYYEHQHNYIKKIFHHNEL
